var title_f43_40_44672="Normal postoperative UGI series after sleeve gastrectomy";
var content_f43_40_44672=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F82047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F82047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal postoperative upper gastrointestinal (UGI) series after sleeve gastrectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 428px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Upside down \"7\" view in normal postoperative sleeve gastrectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44672=[""].join("\n");
var outline_f43_40_44672=null;
var title_f43_40_44673="Heliotrope rash in DM PI";
var content_f43_40_44673=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F60243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F60243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heliotrope rash in dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A reddish-purple eruption on the upper eyelid (the heliotrope rash), accompanied by swelling of the eyelid in a patient with dermatomyositis. This is the most specific rash in DM, although it is only present in a minority of patients.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H Stone, MD, MPH",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44673=[""].join("\n");
var outline_f43_40_44673=null;
var title_f43_40_44674="Asthma daily diary I";
var content_f43_40_44674=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 619px\">",
"   <div class=\"ttl\">",
"    Asthma Diary",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 599px; height: 771px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Use the symptom severity key to give a numerical value to the severity of your asthma. In the notes section, note any triggers that seem to affect your asthma on the day it occurs. Triggers can include colds or infections, exercise, irritants, allergens, and cold air.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44674=[""].join("\n");
var outline_f43_40_44674=null;
var title_f43_40_44675="Angiodysplasia colon gross";
var content_f43_40_44675=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 492px\">",
"   <div class=\"ttl\">",
"    Angiodysplasia of the colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 472px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gross specimen of the colon with angiodysplasia shows a focal mucosal hemorrhagic area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44675=[""].join("\n");
var outline_f43_40_44675=null;
var title_f43_40_44676="Ciclopirox: Drug information";
var content_f43_40_44676=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ciclopirox: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?38/32/39428?source=see_link\">",
"    see \"Ciclopirox: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/62/42979?source=see_link\">",
"    see \"Ciclopirox: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F151212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ciclodan&reg;;",
"     </li>",
"     <li>",
"      Ciclodan&reg; Kit;",
"     </li>",
"     <li>",
"      Loprox&reg;;",
"     </li>",
"     <li>",
"      Pedipirox&trade; -4 Kit;",
"     </li>",
"     <li>",
"      Penlac&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F151213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Ciclopirox&reg;;",
"     </li>",
"     <li>",
"      Loprox&reg;;",
"     </li>",
"     <li>",
"      Penlac&reg;;",
"     </li>",
"     <li>",
"      Stieprox&reg;;",
"     </li>",
"     <li>",
"      Taro-Ciclopirox",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F151243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F151215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tinea pedis, tinea corporis:",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cream and suspension:",
"     </i>",
"     Apply twice daily, gently massage into affected areas; if no improvement after 4 weeks of treatment, re-evaluate the diagnosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gel: Apply twice daily, gently massage into affected areas and surrounding skin; if no improvement after 4 weeks of treatment, re-evaluate diagnosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tinea cruris, cutaneous candidiasis, and tinea versicolor:",
"     </b>",
"     Topical:",
"     <i>",
"      Cream and suspension:",
"     </i>",
"     Apply twice daily, gently massage into affected areas; if no improvement after 4 weeks of treatment, re-evaluate the diagnosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Onychomycosis of the fingernails and toenails:",
"     </b>",
"     Topical:",
"     <i>",
"      Lacquer (solution):",
"     </i>",
"     Apply to adjacent skin and affected nails daily (as a part of a comprehensive management program for onychomycosis). Remove with alcohol every 7 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seborrheic dermatitis of the scalp:",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Gel:",
"     </i>",
"     Apply twice daily, gently massage into affected areas and surrounding skin; if no improvement after 4 weeks of treatment, re-evaluate diagnosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Shampoo:",
"     </i>",
"     Apply ~5 mL to wet hair; lather, and leave in place ~3 minutes; rinse. May use up to 10 mL for longer hair. Repeat twice weekly for 4 weeks; allow a minimum of 3 days between applications; if no improvement after 4 weeks of treatment, re-evaluate diagnosis.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F151228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/62/42979?source=see_link\">",
"      see \"Ciclopirox: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tinea pedis, tinea corporis:",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Cream and suspension:",
"     </i>",
"     Children &gt;10 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Gel:",
"     </i>",
"     Children &gt;16 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tinea cruris, cutaneous candidiasis, and tinea versicolor:",
"     </b>",
"     Topical:",
"     <i>",
"      Cream and suspension:",
"     </i>",
"     Children &gt;10 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Onychomycosis of the fingernails and toenails:",
"     </b>",
"     Topical:",
"     <i>",
"      Lacquer (solution):",
"     </i>",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seborrheic dermatitis of the scalp:",
"     </b>",
"     Topical:",
"     <i>",
"      Gel and shampoo:",
"     </i>",
"     Children &gt;16 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F151216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F151195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical, as olamine: 0.77% (15 g, 30 g, 90 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical: 0.77% (30 g, 45 g, 100 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Loprox&reg;: 0.77% (30 g, 45 g, 100 g) [contains isopropyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Shampoo, topical: 1% (120 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Loprox&reg;: 1% (120 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, topical [nail lacquer]: 8% (6.6 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ciclodan&reg;: 8% (6.6 mL) [contains isopropyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ciclodan&reg; Kit: 8% (6.6 mL) [contains isopropyl alcohol; packaged with Toetal Fresh&trade;]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pedipirox&trade; -4 Kit: 8% (1s) [contains isopropyl alcohol; kit contains one Pedipirox&trade; 6.6 mL, one Pedipirox&trade; 3.3 mL, 15  nail lacquer removal pads, nail file, and pedi-sorb&trade; foot powder]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Penlac&reg;: 8% (6.6 mL) [contains isopropyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, topical, as olamine: 0.77% (30 mL, 60 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F151182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F151197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, suspension: Gently massage into affected areas.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel: Gently massage into clean, affected areas and adjacent skin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lacquer (solution): Apply evenly over nail and surrounding skin at bedtime (or allow 8 hours before washing); apply daily over previous coat for 7 days; after 7 days, may remove with alcohol and continue cycle.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Shampoo: Apply to wet hair; lather and leave in place for ~3 minutes; rinse.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F151196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream/suspension: Treatment of tinea pedis (athlete's foot), tinea cruris (jock itch), tinea corporis (ringworm), cutaneous candidiasis, and tinea versicolor (pityriasis)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel: Treatment of tinea pedis (athlete's foot), tinea corporis (ringworm); seborrheic dermatitis of the scalp",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lacquer (solution): Topical treatment of mild-to-moderate onychomycosis of the fingernails and toenails due to",
"     <i>",
"      Trichophyton rubrum",
"     </i>",
"     (not involving the lunula) and the immediately-adjacent skin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Shampoo: Treatment of seborrheic dermatitis of the scalp",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F151241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Ventricular tachycardia (shampoo)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, alopecia, contact dermatitis, dry skin, erythema, facial edema, hair discoloration (rare; shampoo formulation in light-haired individuals), nail disorder (shape or color change with lacquer), pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Burning sensation (gel: 7% to 34%; &le;1% with other forms), irritation, pain, or redness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Eye pain",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F151200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ciclopirox or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F151186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Irritation: Discontinue if sensitivity or irritation occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunocompromised patients: Use has not been evaluated in immunosuppressed or immunocompromised patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Nail lacquer: For topical use only and has not been studied in conjunction with systemic therapy or in patients with type 1 diabetes mellitus (insulin dependent, IDDM).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For topical use only; avoid contact with eyes or mucous membranes. Use of occlusive dressings or wrappings should be avoided.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F151190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F151192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F151202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies, however, there are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if clearly needed.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F151217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F151201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Ciclodan External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.77% (90 g): $221.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Ciclopirox Olamine External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.77% (30 g): $56.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Ciclopirox External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.77% (45 g): $121.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Loprox External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.77% (45 g): $313.48",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Ciclodan Solution External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8% (34.6 mL): $229.93",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Ciclopirox-Vitamin E External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8 &amp; 5% (1): $202.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Pedipirox-4 Nail External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8% (1): $170.69",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Shampoo",
"     </b>",
"     (Ciclopirox External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (120 mL): $147.35",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Shampoo",
"     </b>",
"     (Loprox External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (120 mL): $388.04",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Ciclodan External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8% (6.6 mL): $201.13",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Ciclopirox External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8% (6.6 mL): $50.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Penlac External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8% (6.6 mL): $602.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Ciclopirox Olamine External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.77% (30 mL): $48.54",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F151203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Batrafan (IN);",
"     </li>",
"     <li>",
"      Batrafen (AE, AT, BB, BD, BG, BH, BM, BS, BZ, CH, CL, CN, CY, CZ, DE, EE, EG, GY, HK, HN, HR, HU, ID, IQ, IR, IT, JM, JO, JP, KW, LB, LY, NL, NZ, OM, PE, PK, PL, PR, PY, QA, RU, SA, SG, SR, SY, TT, UY, VE, YE);",
"     </li>",
"     <li>",
"      Batrafen Gel (DE);",
"     </li>",
"     <li>",
"      Batrafen Nail Lacquer (IL);",
"     </li>",
"     <li>",
"      Brumixol (IT, TW);",
"     </li>",
"     <li>",
"      Canolen (TR);",
"     </li>",
"     <li>",
"      Ciclochem (ES);",
"     </li>",
"     <li>",
"      Fungopirox (PE);",
"     </li>",
"     <li>",
"      Huanli (CL);",
"     </li>",
"     <li>",
"      Loprox (AR, BR, CR, DO, EC, GT, MX, NI, PA, SV, TH);",
"     </li>",
"     <li>",
"      Loprox Laca (MX);",
"     </li>",
"     <li>",
"      Loprox Naillacquer (KP);",
"     </li>",
"     <li>",
"      Miclast (IT);",
"     </li>",
"     <li>",
"      Micopirox (AR);",
"     </li>",
"     <li>",
"      Micoxolamina (IT);",
"     </li>",
"     <li>",
"      Mycofen (DK);",
"     </li>",
"     <li>",
"      Myconail (IL);",
"     </li>",
"     <li>",
"      Mycoster (FR, IL, LU, PT);",
"     </li>",
"     <li>",
"      Nail Batrafen (NZ);",
"     </li>",
"     <li>",
"      Naillacquer (KP);",
"     </li>",
"     <li>",
"      Primax (CO);",
"     </li>",
"     <li>",
"      Stieprox (AU, FI, GR, IE, MY, NO, PH, SG, TH, TW);",
"     </li>",
"     <li>",
"      Stiprox (MX, PE);",
"     </li>",
"     <li>",
"      Tolnaderm (MY)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F151185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibiting transport of essential elements in the fungal cell disrupting the synthesis of DNA, RNA, and protein",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F151199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Cream, suspension: &lt;2% through intact skin; increased with gel; &lt;5% with lacquer",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Scalp application: To epidermis, corium (dermis), including hair, hair follicles, and sebaceous glands",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 94% to 98%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Biologic: Cream, suspension: 1.7 hours; Elimination: Gel: 5.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (gel: 3% to 10%); feces (small amounts)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9263 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-6AD27EA953-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44676=[""].join("\n");
var outline_f43_40_44676=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151212\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151213\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151243\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151215\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151228\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151216\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682652\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682653\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151195\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151182\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151197\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151196\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151241\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151200\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151186\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299041\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151190\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151192\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151202\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151217\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151201\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151203\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151185\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F151199\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9263\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9263|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?38/32/39428?source=related_link\">",
"      Ciclopirox: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/62/42979?source=related_link\">",
"      Ciclopirox: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_40_44677="Prehypertension";
var content_f43_40_44677=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prehypertension",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44677/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44677/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44677/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44677/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44677/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44677/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/40/44677/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term follow-up of patients destined to develop essential (primary) hypertension demonstrates that blood pressure (BP) readings gradually increase over time. They may initially be normal, then prehypertensive (or high-normal), and then intermittently elevated; however, the readings may show considerable variability or lability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The seventh report of the Joint National Committee (JNC 7) published in 2003 proposed the following classification based upon the average of two or more properly measured readings at each of",
"    <strong>",
"     two or more visits after an initial screen",
"    </strong>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal blood pressure &mdash; systolic &lt;120 mmHg",
"      <strong>",
"       AND",
"      </strong>",
"      diastolic &lt;80 mmHg",
"     </li>",
"     <li>",
"      Prehypertension &mdash; systolic 120 to 139 mmHg",
"      <strong>",
"       OR",
"      </strong>",
"      diastolic 80 to 89 mmHg",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, trials have identified groups of patients at higher risk in whom goal blood pressures below",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    mmHg may be associated with improved outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/40/33417?source=see_link\">",
"     \"What is goal blood pressure in the treatment of hypertension?\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of prehypertension among adults in the United States is approximately 37 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple epidemiologic studies have demonstrated an increase in cardiovascular risk in patients with prehypertension:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Framingham Heart Study examined the risk of cardiovascular disease at 10 year follow-up among subjects with high-normal blood pressure at baseline examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/3\">",
"       3",
"      </a>",
"      ]. After adjustment for cardiovascular risk factors and when compared to those with optimal blood pressure, the hazard ratios for a cardiovascular event at 10 years for those with high-normal values (130 to",
"      <span class=\"nowrap\">",
"       139/85",
"      </span>",
"      to 89 mmHg) were 2.5 and 1.6 for women and men, respectively (",
"      <a class=\"graphic graphic_figure graphicRef82189 \" href=\"mobipreview.htm?42/40/43662\">",
"       figure 1",
"      </a>",
"      ). An increased hazard ratio was also observed in those with normal values (120 to",
"      <span class=\"nowrap\">",
"       129/80",
"      </span>",
"      to 84 mmHg) compared with participants with optimal (called normal in JNC 7) blood pressures",
"      <span class=\"nowrap\">",
"       (&lt;120/&lt;80",
"      </span>",
"      mmHg).",
"     </li>",
"     <li>",
"      A subsequent analysis of data from the Framingham Heart Study demonstrated that relative to blood pressure",
"      <span class=\"nowrap\">",
"       &lt;120/80",
"      </span>",
"      mmHg, prehypertension (120 to",
"      <span class=\"nowrap\">",
"       129/80",
"      </span>",
"      to 84 mmHg) was associated with an increased risk of myocardial infarction (relative risk 3.5) and coronary artery disease (relative risk 1.7), but not stroke [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the Women's Health Initiative study involving over 60,785 postmenopausal women who were followed for 7.7 years, women with prehypertension, compared to normotensive individuals, had an increased risk of cardiovascular death (HR 1.76, 95% CI 1.40 to 2.2), myocardial infarction (1.93, 95% CI 1.49 to 2.50) and stroke (1.36, 95% CI 1.05 to 1.77) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with prehypertension also appear to have a greater prevalence of traditional cardiovascular risk factors than those with normal blood pressures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the increase in cardiovascular risk associated with prehypertension cannot be explained entirely by a higher prevalence of other cardiovascular factors. This was illustrated in a substudy of the Strong Heart Study, in which the risk of incident cardiovascular events at 12 years was higher in patients with prehypertension and diabetes than in those with either risk factor alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There also appears to be an association between prehypertension and microalbuminuria, a risk factor for cardiovascular disease and early cardiovascular mortality. An increased incidence of microalbuminuria was observed among individuals with &ldquo;high-normal&rdquo; blood pressure (now called prehypertension) compared to those with &ldquo;optimal&rdquo; blood pressure (odds ratio of 2.1) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/16/20745?source=see_link\">",
"     \"High albuminuria (microalbuminuria) and cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PROGRESSION TO SUSTAINED HYPERTENSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a result of the rise in BP with time, the prevalence of hypertension increases from approximately 10 percent at age 30 to as high as 90 percent after age 65 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Predictors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate at which new onset hypertension occurs varies importantly with the blood pressure at baseline. The magnitude of this effect is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A report from the Framingham Heart Study examined the incidence of hypertension (defined as blood pressure greater than",
"      <span class=\"nowrap\">",
"       140/90",
"      </span>",
"      mmHg or use of antihypertensive agent) over a four year period among patients who initially had optimal (less than",
"      <span class=\"nowrap\">",
"       120/80",
"      </span>",
"      mmHg), normal",
"      <span class=\"nowrap\">",
"       (120-129/80-84",
"      </span>",
"      mmHg) or high-normal",
"      <span class=\"nowrap\">",
"       (130-139/85-89",
"      </span>",
"      mmHg) blood pressures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/9\">",
"       9",
"      </a>",
"      ]. A progressive increase in the frequency of development of hypertension was observed in these three groups; 5, 18, and 37 percent, respectively, under age 65; and 16, 26, and 50 percent, respectively in older subjects.",
"     </li>",
"     <li>",
"      A later report from the Framingham Heart Study estimated that individuals age 55 to 65 who do not have hypertension have a lifetime risk of developing hypertension (mostly mild) of approximately 90 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The differential incidence of isolated diastolic hypertension (IDH, blood pressure",
"      <span class=\"nowrap\">",
"       &lt;140/&ge;90",
"      </span>",
"      mmHg) and isolated systolic hypertension (ISH, blood pressure",
"      <span class=\"nowrap\">",
"       &ge;140/&lt;90",
"      </span>",
"      mmHg) was examined in another report from the Framingham Heart Study with a mean follow-up time of 10 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/11\">",
"       11",
"      </a>",
"      ]. Patients started on antihypertensive therapy were censored. The following findings were noted:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Among patients who initially had optimal (less than",
"      <span class=\"nowrap\">",
"       120/80",
"      </span>",
"      mmHg), normal",
"      <span class=\"nowrap\">",
"       (120-129/80-84",
"      </span>",
"      mmHg) or high-normal",
"      <span class=\"nowrap\">",
"       (130-139/85-89",
"      </span>",
"      mmHg) blood pressures, the incidence of new onset IDH was 3, 8 and 10 per 1000 person-years at risk, and the incidence of ISH was 6, 23 and 35 per 1000 person-years at risk. The incidence of systolic and diastolic hypertension was intermediate.",
"     </li>",
"     <li>",
"      Predictors of IDH were younger age and increased body weight, and there was a high probability of progression to systolic and diastolic hypertension at 6.7 years (55 percent, adjusted hazard ratio 23.1), suggesting that IDH is not a benign condition.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/4/4169?source=see_link&amp;anchor=H8#H8\">",
"     \"Hypertension: Who should be treated?\", section on 'Isolated diastolic hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Predictors of ISH were older age and increased body weight. ISH appeared to arise more commonly from normal and high-normal blood pressure than from \"burned out\" diastolic hypertension.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Framingham hypertension risk prediction score",
"    </span>",
"    &nbsp;&mdash;&nbsp;The identification of prehypertensive patients who are at greatest risk for progression to hypertension may allow for more intensive targeted therapy to prevent or delay the onset of hypertension. Using data from the Framingham Heart Study, a risk calculator has been developed to estimate the risk of developing hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/12\">",
"     12",
"    </a>",
"    ]. Clinical variables including age, blood pressure, body mass index (all continuous variables), sex, family history of hypertension, and smoking predict the development of hypertension in nondiabetic individuals. The most important predictors were higher blood pressure and older age.",
"   </p>",
"   <p>",
"    The four-year risk of developing hypertension was classified as low (less than 5 percent) in 34 percent, medium (5 to 10 percent) in 19 percent, and high (more than 10 percent) in 47 percent. The utility of this risk calculator in diabetic patients and in nonwhite cohorts remains to be tested.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Preventive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TRial of Preventing HYpertension (TROPHY) study examined whether antihypertensive therapy in patients with prehypertension will prevent progression to clinical hypertension that persists after the antihypertensive drug is discontinued [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/13\">",
"     13",
"    </a>",
"    ]. In this four year trial, 806 patients with systolic blood pressures of 130 to 139 mmHg",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diastolic pressures of 85 to 89 mmHg were randomly assigned to two years of therapy with either placebo or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/48/38663?source=see_link\">",
"     candesartan",
"    </a>",
"    (16",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"    After two years, all patients continued therapy with placebo for another two years. Baseline blood pressure, body mass index, and plasma creatinine and lipid concentrations were similar in the two groups.",
"   </p>",
"   <p>",
"    The main outcome measure was the development of hypertension, defined as average blood pressure",
"    <span class=\"nowrap\">",
"     &ge;140/90",
"    </span>",
"    mmHg at any three clinic visits, any single reading",
"    <span class=\"nowrap\">",
"     &ge;160/100",
"    </span>",
"    mmHg, use of antihypertensive medications, or blood pressure",
"    <span class=\"nowrap\">",
"     &ge;140/90",
"    </span>",
"    mmHg at the four-year visit. &nbsp;The following significant benefits were noted with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/48/38663?source=see_link\">",
"     candesartan",
"    </a>",
"    therapy, although there were important limitations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As expected,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/48/38663?source=see_link\">",
"       candesartan",
"      </a>",
"      therapy resulted in a lower rate of hypertension at some point during the two years of active therapy (14 versus 40 percent with placebo). In addition, the rate of hypertension was significantly lower in treated patients at four years (53 versus 63 percent). However, this was driven by a lower proportion of patients with blood pressure",
"      <span class=\"nowrap\">",
"       &ge;140/90",
"      </span>",
"      mmHg at any three clinic visits, which included the first two years of active therapy and did not have to be consecutive clinic visits. The proportions of patients with the other components of the primary end point were similar in the two groups. In particular, at study end, there were no differences between the two groups in the proportion of patients who required antihypertensive therapy (12 versus 13 percent).",
"     </li>",
"     <li>",
"      At two years, the systolic and diastolic pressures were significantly lower with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/48/38663?source=see_link\">",
"       candesartan",
"      </a>",
"      therapy compared to placebo. However, within nine months of cessation of candesartan therapy, the pressures rose to values similar to those in the placebo group (",
"      <a class=\"graphic graphic_figure graphicRef65042 \" href=\"mobipreview.htm?14/42/15022\">",
"       figure 2",
"      </a>",
"      ). The same findings were noted in the much larger Medical Research Council trial of mild hypertension, which demonstrated that after five to six years of active therapy with a thiazide diuretic or beta blocker, cessation of therapy resulted in a rise in blood pressure that, within six months, was not distinguishable from the placebo group that had not been treated from trial onset (",
"      <a class=\"graphic graphic_figure graphicRef69497 \" href=\"mobipreview.htm?7/4/7232\">",
"       figure 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/15\">",
"       15",
"      </a>",
"      ]. In contrast, patients continued on active therapy maintained the fall in blood pressure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/41/18068?source=see_link\">",
"       \"Can therapy be discontinued in well-controlled hypertension?\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The inability to change the natural history of prehypertension may be due in part to the timing of preventive therapy. In the spontaneously hypertensive rat, antihypertensive therapy must be given within the first two to six weeks of life (comparable with late childhood in humans) in order to prevent the otherwise inexorable development of hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/16\">",
"     16",
"    </a>",
"    ]. Similar observations were made in transgenic mice with an inducible renin-angiotensin system (RAS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/17\">",
"     17",
"    </a>",
"    ]. Transient (four-week) activation of the RAS produced sustained elevations in blood pressure in young, but not adult, mice. Thus, humans with prehypertension may be beyond the period of time when prevention is possible.",
"   </p>",
"   <p>",
"    In summary, there is no convincing evidence that transient antihypertensive therapy changes the course of prehypertension or hypertension. Further study is required to determine the role, if any, of pharmacotherapy in prehypertension among individuals without other indications for such therapy (eg, chronic kidney disease, heart failure).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal interval for screening for hypertension is not known. The 2007 United States Preventive Services Task Force (USPSTF) guidelines recommend screening every two years for persons with systolic and diastolic pressures below 120 mmHg and 80 mmHg, respectively, and yearly for persons with a systolic pressure of 120 to 139 mmHg or a diastolic pressure of 80 to 89 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful monitoring for signs of end-organ damage or progression to hypertension is an important part of the follow-up of patients with prehypertension. Any change in BP classification should be confirmed on at least one subsequent visit.",
"   </p>",
"   <p>",
"    We agree with JNC 7 that patients with prehypertension who do not have diabetes, chronic kidney disease, end-organ damage, or clinical evidence of cardiovascular disease are generally treated with nonpharmacologic therapies such as weight reduction, sodium restriction, increased physical activity, and avoidance of excess alcohol (",
"    <a class=\"graphic graphic_table graphicRef62129 \" href=\"mobipreview.htm?42/24/43403\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42679?source=see_link\">",
"     \"Diet in the treatment and prevention of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The major indication for antihypertensive drug therapy is progression to overt hypertension defined in average risk patients as a BP",
"    <span class=\"nowrap\">",
"     &ge;140/&ge;90",
"    </span>",
"    mmHg. There is evidence supporting a lower goal blood pressure in patients with atherosclerotic cardiovascular disease, diabetes mellitus, or chronic kidney disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/19\">",
"     19",
"    </a>",
"    ]. The supportive data are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/40/33417?source=see_link\">",
"     \"What is goal blood pressure in the treatment of hypertension?\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=see_link&amp;anchor=H15#H15\">",
"     \"Blood pressure management in patients with atherosclerotic cardiovascular disease\", section on 'Goal blood pressure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of hypertension in patients with diabetes mellitus\", section on 'Goal blood pressure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=see_link&amp;anchor=H24#H24\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\", section on 'Blood pressure goal'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H296552169\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The seventh report of the Joint National Committee (JNC 7) published in 2003 proposed the following classification based upon the average of two or more properly measured readings at each of",
"      <strong>",
"       two or more visits after an initial screen",
"      </strong>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44677/abstract/1\">",
"       1",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Normal blood pressure &mdash; systolic &lt;120 mmHg",
"      <strong>",
"       AND",
"      </strong>",
"      diastolic &lt;80 mmHg",
"     </li>",
"     <li>",
"      Prehypertension &mdash; systolic 120 to 139 mmHg",
"      <strong>",
"       OR",
"      </strong>",
"      diastolic 80 to 89 mmHg",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The prevalence of prehypertension among adults in the United States is approximately 37 percent. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Prevalence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple epidemiologic studies have shown that patients with prehypertension have an increased risk of cardiovascular disease that is independent of other coexistent cardiovascular risk factors. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Cardiovascular risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prehypertension is a strong predictor of the development of hypertension, reflecting the fact that blood pressure tends to increase as people age. In one study, 18 to 26 percent of individuals whose blood pressures were",
"      <span class=\"nowrap\">",
"       120-129/80-84",
"      </span>",
"      mmHg and 37 to 50 percent of individuals whose blood pressures were",
"      <span class=\"nowrap\">",
"       130-139/85-89",
"      </span>",
"      mmHg developed hypertension over a five-year period. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Progression to sustained hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is",
"      <strong>",
"       no",
"      </strong>",
"      convincing evidence that transient antihypertensive therapy changes the course of prehypertension or prevents the development of hypertension. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Preventive therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with prehypertension who do not have diabetes, chronic kidney disease, end-organ damage, or clinical evidence of cardiovascular disease are generally treated with nonpharmacologic therapies such as weight reduction, sodium restriction, increased physical activity, and avoidance of excess alcohol (",
"      <a class=\"graphic graphic_table graphicRef62129 \" href=\"mobipreview.htm?42/24/43403\">",
"       table 1",
"      </a>",
"      ). The major indication for antihypertensive drug therapy is progression to overt hypertension. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/1\">",
"      Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/2\">",
"      Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 2011; 123:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/3\">",
"      Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/4\">",
"      Qureshi AI, Suri MF, Kirmani JF, et al. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005; 36:1859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/5\">",
"      Hsia J, Margolis KL, Eaton CB, et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007; 115:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/6\">",
"      Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004; 164:2113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/7\">",
"      Pletcher MJ, Bibbins-Domingo K, Lewis CE, et al. Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med 2008; 149:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/8\">",
"      Zhang Y, Lee ET, Devereux RB, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006; 47:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/9\">",
"      Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/10\">",
"      Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/11\">",
"      Franklin SS, Pio JR, Wong ND, et al. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation 2005; 111:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/12\">",
"      Parikh NI, Pencina MJ, Wang TJ, et al. A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med 2008; 148:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/13\">",
"      Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/14\">",
"      Schunkert H. Pharmacotherapy for prehypertension--mission accomplished? N Engl J Med 2006; 354:1742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/15\">",
"      Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension. Br Med J (Clin Res Ed) 1986; 293:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/16\">",
"      Sasamura H, Hayashi K, Ishiguro K, et al. Prevention and regression of hypertension: role of renal microvascular protection. Hypertens Res 2009; 32:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/17\">",
"      Heijnen BF, Peutz-Kootstra CJ, Mullins JJ, et al. Transient renin-angiotensin system stimulation in an early stage of life causes sustained hypertension in rats. J Hypertens 2011; 29:2369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/18\">",
"      U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2007; 147:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44677/abstract/19\">",
"      Thompson AM, Hu T, Eshelbrenner CL, et al. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA 2011; 305:913.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3817 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-06EB330AA9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44677=[""].join("\n");
var outline_f43_40_44677=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H296552169\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CARDIOVASCULAR RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PROGRESSION TO SUSTAINED HYPERTENSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Predictors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Framingham hypertension risk prediction score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Preventive therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H296552169\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3817\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3817|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/40/43662\" title=\"figure 1\">",
"      CV risk and BP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/42/15022\" title=\"figure 2\">",
"      Candesartan prehypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/4/7232\" title=\"figure 3\">",
"      Rapid rise in blood pressure after discontinuation of chronic antihypertensive therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3817|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/24/43403\" title=\"table 1\">",
"      Lifestyle modifications in HTN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/2/29737?source=related_link\">",
"      Blood pressure management in patients with atherosclerotic cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/41/18068?source=related_link\">",
"      Can therapy be discontinued in well-controlled hypertension?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42679?source=related_link\">",
"      Diet in the treatment and prevention of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/16/20745?source=related_link\">",
"      High albuminuria (microalbuminuria) and cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/4/4169?source=related_link\">",
"      Hypertension: Who should be treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/45/21210?source=related_link\">",
"      Treatment of hypertension in patients with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/40/33417?source=related_link\">",
"      What is goal blood pressure in the treatment of hypertension?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_40_44678="Transmission US in RA";
var content_f43_40_44678=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F79911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F79911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transmission ultrasonography in RA",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 315px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transmission ultrasonography showing a distended joint capsule in the proximal interphalangeal joint (arrow) of a patient with rheumatoid arthritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Owen DS. Aspiration and injection of joints in soft tissue. In: Textbook of Rheumatology, 4th, Kelley WN, Harris ED Jr, Ruddy S, et al (Eds), WB Saunders, Philadelphia 1993. p.545.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44678=[""].join("\n");
var outline_f43_40_44678=null;
var title_f43_40_44679="Association between Helicobacter pylori infection and duodenal ulcer";
var content_f43_40_44679=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Association between Helicobacter pylori infection and duodenal ulcer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44679/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44679/contributors\">",
"     Sheila E Crowe, MD, FRCPC, FACP, FACG, AGAF",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44679/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44679/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44679/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44679/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/40/44679/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 25, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with duodenal ulcer (DU) are infected with Helicobacter pylori (H. pylori). However, in multicenter trials, H. pylori was absent in almost 30 percent of patients with an endoscopically documented duodenal ulcer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/1\">",
"     1",
"    </a>",
"    ]. Studies that have investigated these patients found that they have generally had a shorter duration of symptoms and that many had regularly used nonsteroidal antiinflammatory drugs (NSAIDs) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Such patients have a significantly worse outcome, especially if treated empirically for H. pylori infection. Thus, H. pylori status should be determined in all ulcer patients before initiating treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/4\">",
"     4",
"    </a>",
"    ]. High acid output may be a cause of recurrent DU in patients in whom H. pylori has been eradicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/5\">",
"     5",
"    </a>",
"    ]. A variety of other causes are responsible for the remaining cases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/0/19466?source=see_link\">",
"     \"Unusual causes of peptic ulcer disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The link between H. pylori and DU will be reviewed here. The pathophysiology of H. pylori infection as it relates to gastrointestinal disease in general is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=see_link\">",
"     \"Pathophysiology of and immune response to Helicobacter pylori infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EVIDENCE LINKING HELICOBACTER PYLORI TO DUODENAL ULCERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several lines of evidence that implicate H. pylori as a major etiologic factor in duodenal ulcers (DU):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      H. pylori is present in most patients who have a DU that is not related to NSAID use",
"     </li>",
"     <li>",
"      H. pylori infection is detectable before the occurrence of DU and appears to be a risk factor for the disorder",
"     </li>",
"     <li>",
"      Eradication of H. pylori prevents DU recurrence",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Incidence of H. pylori in patients with duodenal ulcer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early studies noted a high incidence of H. pylori infection (then called Campylobacter pylori) in patients with DU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/6\">",
"     6",
"    </a>",
"    ]; subsequent reviews confirmed that H. pylori is detectable in 80 to 95 percent of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/2,7\">",
"     2,7",
"    </a>",
"    ]. These data were supported by reports which found that the prevalence of H. pylori is negligible in populations in which ulcer disease is rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of H. pylori in patients with DU is changing in some parts of the world. While H. pylori infection remains very common in patients from Asia with DU, it is becoming less common in patients from the United States and parts of Europe. In an epidemiologic study from China, 1030 patients underwent endoscopy and 73 percent were found to have H. pylori [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/9\">",
"     9",
"    </a>",
"    ]. Peptic ulcers were present in 17 percent, more than two-thirds of which were duodenal ulcers. Among those with peptic ulcers, the prevalence of H. pylori infection was 93 percent. On the other hand, in the United States and parts of Europe, the prevalence of H. pylori in patients with ulcer disease appears to be falling and is now in the range of 50 to 75 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/42/19113?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology and etiology of peptic ulcer disease\", section on 'H. pylori'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While the association between H. pylori and DU is strong, it is not specific. As examples, H. pylori infection is also found in patients with gastric ulcers (65 to 95 percent), dyspepsia (20 to 60 percent), gastric cancer (70 to 90 percent), and asymptomatic patients (20 to 45 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/4/27720?source=see_link\">",
"     \"Approach to the patient with dyspepsia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=see_link\">",
"     \"Association between Helicobacter pylori infection and gastrointestinal malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     H. pylori occurs before manifestations of the disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several trials have found that preexisting H. pylori infection is a risk factor for the development of DU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. One study, for example, reviewed the cases of more than 5000 native Hawaiians who had stored serum from the late 1960s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/11\">",
"     11",
"    </a>",
"    ]. Of the 65 patients who developed DU over the next 20 years, 92 percent were H. pylori positive versus 78 percent of controls, producing an odds ratio of 4.0. Similarly, an endoscopic study that included 526 patients with long-term follow-up found that the odds ratio of developing DU was 5.0 for those with preexisting H. pylori infection compared with H. pylori negative subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Eradication of H. pylori reduces disease recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of H. pylori infection in patients with DU decreases the incidence of ulcer recurrence. One meta-analysis examined the recurrence rate for DU after at least six months of follow-up. The recurrence rate was 6 percent if H. pylori was eradicated and 67 percent if it was not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/14\">",
"     14",
"    </a>",
"    ]. A second meta-analysis found recurrence rates of 20 and 56 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/15\">",
"     15",
"    </a>",
"    ]. The studies in the meta-analyses used endoscopic findings to define ulcer recurrence. It should be noted that the rate of symptomatic recurrence is lower. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12455?source=see_link&amp;anchor=H7#H7\">",
"     \"Management of duodenal ulcers in patients infected with Helicobacter pylori\", section on 'Disease recurrence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF ULCER FORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The precise mechanism by which H. pylori contributes to duodenal ulcer (DU) formation is incompletely understood. However, the bacterium appears to affect the following aspects of intestinal and mucosal physiology:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased gastric acid secretion",
"     </li>",
"     <li>",
"      Gastric metaplasia",
"     </li>",
"     <li>",
"      Immune response",
"     </li>",
"     <li>",
"      Mucosal defense mechanisms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There may also be a contribution from a variety of bacterial, host, and environmental factors that have a role in the pathogenesis of ulcer formation (",
"    <a class=\"graphic graphic_algorithm graphicRef73521 \" href=\"mobipreview.htm?7/34/7727\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Increased gastric acid secretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute H. pylori infection induces a short period of hypochlorhydria. In contrast, chronic infection often leads to increases in basal and stimulated acid output, particularly in patients who develop DUs (",
"    <a class=\"graphic graphic_figure graphicRef54104 \" href=\"mobipreview.htm?39/24/40333\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. In addition, following H. pylori eradication, mean basal and stimulated acid output drops by 50 percent at one month and returns to normal levels by one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One mechanism by which H. pylori may enhance gastric acid secretion is via increased release of gastrin. Gastrin is responsible for gastric acid secretion in normal subjects by two mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It has a trophic action on parietal cells and histamine-secreting enterochromaffin-like (ECL) cells",
"     </li>",
"     <li>",
"      It stimulates parietal cells largely via the release of histamine",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This process is tightly controlled by a second hormone, somatostatin, which is a potent inhibitor of gastrin synthesis, gastrin release, and gastric acid secretion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/30/29160?source=see_link\">",
"     \"Physiology of gastric acid secretion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with H. pylori infection have elevated basal and stimulated concentrations of serum gastrin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/16,18\">",
"     16,18",
"    </a>",
"    ] and a decreased concentration of somatostatin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/19\">",
"     19",
"    </a>",
"    ]. The peak acid output achieved after stimulation with gastrin releasing peptide, regarded as a measure of the stomach's functional response to endogenous gastrin, is also increased threefold in healthy H. pylori-positive patients, and sixfold in those with DU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. These values completely normalize within one year of H. pylori eradication (",
"    <a class=\"graphic graphic_figure graphicRef54104 \" href=\"mobipreview.htm?39/24/40333\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The peak acid output after pentagastrin stimulation (PAOPg), a measure of the functional parietal cell population, is also significantly increased in H. pylori-associated DU disease. However, there are conflicting data regarding the effect of H. pylori eradication on PAOPg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/16,21,22\">",
"     16,21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism of the increased acid response in patients infected with H. pylori who have DU disease compared with infected healthy patients is unclear. One study suggests that it may be due to the combination of decreased sensitivity to gastrin in healthy patients, and increased maximal acid secretory capacity in those with DU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Suppression of somatostatin (rather than an increase in gastrin secreting cells) is probably the initial event that then leads to the hypergastrinemia that is evident in patients with DU and H. pylori. This hypothesis is supported by a study of 28 infected patients with DU that found that after the infection was successfully eradicated, the median density of somatostatin-immunoreactive cells (antral D cells) increased from 9 to 19",
"    <span class=\"nowrap\">",
"     cells/mm",
"    </span>",
"    muscularis mucosa, while the median somatostatin",
"    <span class=\"nowrap\">",
"     mRNA/rRNA",
"    </span>",
"    ratio increased from 50 to 95 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/24\">",
"     24",
"    </a>",
"    ]. In contrast, the number of gastrin-immunoreactive cells and the quantity of gastrin mRNA did not change significantly. The role of H. pylori in this process is supported by studies that have shown eradication of infection reverses the abnormalities in gastrin and gastric acid secretion (",
"    <a class=\"graphic graphic_figure graphicRef54104 \" href=\"mobipreview.htm?39/24/40333\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/16,21\">",
"     16,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, hypergastrinemia alone probably does not explain the increases in acid output in patients infected with H. pylori; gastrin levels often return to normal within one month after eradication, while mean basal and peak acid output remain elevated for longer periods of time. In addition, H. pylori itself does not appear to alter the sensitivity of gastric parietal cells to gastrin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/25\">",
"     25",
"    </a>",
"    ], although hypergastrinemia may have trophic effects over time that result in increased parietal cell mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Gastric metaplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric metaplasia refers to the presence of gastric epithelium in the first portion of the duodenum. This abnormality appears to be a response of the mucosa to excessive acid exposure since it only occurs when the luminal pH is less than 2.5 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/26\">",
"     26",
"    </a>",
"    ]. In addition to acid hypersecretion, impaired duodenal bicarbonate secretion induced by H. pylori also may contribute to the low duodenal luminal pH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The metaplastic foci provide areas for H. pylori colonization, and probably have a role in the development of duodenitis. In one study, for example, 30 of 34 (88 percent) patients with active duodenitis had more than 5 percent gastric metaplasia in duodenal mucosal specimens and H. pylori-associated gastritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/26\">",
"     26",
"    </a>",
"    ]. In contrast, these two factors coexisted in only 0.43 percent of patients with no duodenal inflammation. In addition, when H. pylori was seen histologically in duodenal biopsy specimens, it was confined only to areas of gastric metaplasia, and never occurred in the absence of a polymorphonuclear infiltrate. A more recent study confirmed that the extent of duodenal gastric metaplasia was four-fold greater in HP infected duodenal ulcer patients than in infected asymptomatic controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/28\">",
"     28",
"    </a>",
"    ]. Colonization of the duodenal bulb by HP CagA+ strains was also greater in DU patients than in infected non DU controls (80 versus 30 percent), even though prevalence of CagA+ gastric infection was similar in both groups. These studies support the contention that infection of gastric metaplasia is important in the pathogenesis on DU.",
"   </p>",
"   <p>",
"    H. pylori infection in areas of gastric metaplasia may weaken the mucosa, making it more susceptible to acid injury. This hypothesis is supported by studies which have found that gastric metaplasia increases the relative risk for ulceration fivefold; the presence of H. pylori within these regions increases the risk 50-fold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastric metaplasia is not the same as gastric heterotopia, in which (presumably) congenital patches of gastric-type mucosa occur anywhere in the small or large intestine, although the two entities may be difficult to distinguish. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24185?source=see_link\">",
"     \"Metaplastic (chronic) atrophic gastritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Immune response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although H. pylori is a noninvasive organism, it stimulates a robust inflammatory and immune response that may have a role in DU formation. The response includes increased production of inflammatory cytokines such as interleukin (IL)-1, IL-6, tumor necrosis factor alpha, and most notably, IL-8. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=see_link\">",
"     \"Pathophysiology of and immune response to Helicobacter pylori infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Mucosal defense factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;H. pylori may downregulate several important mucosal defense factors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidermal growth factor (EGF) and transforming growth factor-alpha (TGF alpha) are potent gastric acid inhibitors and stimuli of mucosal growth and protection. One study found that the basal and stimulated release of EGF is significantly increased after eradication of H. pylori, an effect that may play a role in ulcer healing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with DUs have decreased proximal duodenal mucosal bicarbonate production. It is not clear if impaired bicarbonate secretion can be attributed to H. pylori; however, eradication of the infection does result in normalization of bicarbonate output [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      H. pylori itself releases proteases that degrade normally protective mucous glycoproteins that overlie the mucosa [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other contributing factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only 10 to 15 percent of patients with H. pylori infection develop ulcer disease, suggesting that other factors are probably important in determining the outcome of infection. One such factor is the bacterial strain; only strains with the cytotoxin-associated gene A (cagA), coding for a 128-140 kDa protein (CagA), coexpress vacuolating cytotoxin (VacA), a toxin that causes cell injury in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/32\">",
"     32",
"    </a>",
"    ]. Approximately 85 to 100 percent of patients with DU have CagA+ strains, compared with 30 to 60 percent of infected patients who do not develop ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/33\">",
"     33",
"    </a>",
"    ]. However, since CagA+ strains are also associated with gastric cancer, the specificity of the association makes it less clear how the same strain can lead to two very divergent conditions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=see_link\">",
"     \"Pathophysiology of and immune response to Helicobacter pylori infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A specific H. pylori gene, dupA, appears to be associated with development of DU. Those infected with dupA bacteria had more intense antral inflammation, higher levels of IL-8 and less gastric atrophy, intestinal metaplasia, and gastric cancer, a cytokine and histologic profile associated with DU disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/34\">",
"     34",
"    </a>",
"    ]. One study suggested that the dupA gene, which encompasses jhp0917 and jhp0918, was associated with an increased risk of DU and protection against gastric cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, genetic factors may help determine the susceptibility to infection with H. pylori [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/36\">",
"     36",
"    </a>",
"    ]. It has been suggested that patients with H. pylori who develop DU have an intrinsically higher parietal cell mass or sensitivity to gastrin than H. pylori-positive healthy adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/23,29,37\">",
"     23,29,37",
"    </a>",
"    ]. This observation may explain the exaggerated acid response to various stimuli in those who develop DUs. Genetic factors may also determine duodenal cytokine response to infection. In one study, duodenal epithelial cells from patients with a duodenal ulcer had a decreased capacity to produce inflammatory cytokines compared with controls from patients without a DU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Environmental factors such as smoking and nonsteroidal antiinflammatory drug (NSAID) use may also increase the risk of ulcer formation in patients with H. pylori [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/31,39-41\">",
"     31,39-41",
"    </a>",
"    ]. One report noted an increased prevalence of ulcers in H. pylori-infected smokers compared with infected nonsmokers (73 versus 27 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiple studies of variable design have evaluated the relationship between NSAIDs and H. pylori in the development of peptic ulcer disease. The following conclusions were reached in a meta-analysis of 25 such studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Users of NSAIDs with H. pylori infection were 61 times more likely to have a peptic ulcer than non-infected non-NSAID users.",
"     </li>",
"     <li>",
"      Either factor alone increased the risk of ulcer disease by approximately 20-fold.",
"     </li>",
"     <li>",
"      H. pylori infection and NSAID use increased the risk of ulcer bleeding by 1.8 and 4.9-fold, respectively; when present together they increased the risk of ulcer bleeding by 6-fold.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A subsequent meta-analysis of studies published between 1999 and 2008 with a total of 16,080 patients found that the mean prevalence of H. pylori infection in DUs was 81 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/43\">",
"     43",
"    </a>",
"    ]. If only the last five years' literature was considered, the rate was 77 percent. H. pylori-negative DUs were associated with NSAID use in 21 percent of patients when studies with infection rates of less than 90 percent were examined. The majority of the H. pylori negative ulcers were attributed to false-negative H. pylori testing, since even under optimal conditions the sensitivity of testing is below 95 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/44\">",
"     44",
"    </a>",
"    ]. Other causes for H. pylori negative DUs were much less common.",
"   </p>",
"   <p>",
"    NSAID users with a history of peptic ulcer disease should be tested and treated for H. pylori if they are infected; there are also data to suggest that testing and treating (if positive) all patients for H. pylori prior to beginning NSAID use may be warranted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/45,46\">",
"     45,46",
"    </a>",
"    ], although conflicting data have also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44679/abstract/47\">",
"     47",
"    </a>",
"    ], and this is not currently the standard of care. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/37/6745?source=see_link\">",
"     \"NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/53/5971?source=see_link\">",
"       \"Patient information: Peptic ulcers (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/31/19954?source=see_link\">",
"       \"Patient information: H. pylori infection (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/60/964?source=see_link\">",
"       \"Patient information: Peptic ulcer disease (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/58/14242?source=see_link\">",
"       \"Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H100070473\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are several lines of evidence that implicate H. pylori as a major etiologic factor in duodenal ulcers (DUs) (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Evidence linking Helicobacter pylori to duodenal ulcers'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      H. pylori is present in most patients who have a DU that is not related to NSAID use",
"     </li>",
"     <li>",
"      H. pylori infection is detectable before the occurrence of DU and appears to be a risk factor for the disorder",
"     </li>",
"     <li>",
"      Eradication of H. pylori prevents DU recurrence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the United States and parts of Europe, the prevalence of H. pylori in patients with ulcer disease appears to be falling. It is now in the range of 50 to 75 percent but remains high in Asia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Incidence of H. pylori in patients with duodenal ulcer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The precise mechanism by which H. pylori contributes to DU formation is incompletely understood. However, the bacterium appears to affect the following aspects of intestinal and mucosal physiology which may be important (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathogenesis of ulcer formation'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Increased gastric acid secretion",
"     </li>",
"     <li>",
"      Gastric metaplasia",
"     </li>",
"     <li>",
"      Immune response",
"     </li>",
"     <li>",
"      Mucosal defense mechanisms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Only 10 to 15 percent of patients with H. pylori infection develop ulcer disease, suggesting that other factors are probably important in determining the outcome of infection. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Other contributing factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In apparent H. pylori-negative duodenal ulcer a thorough search for infection should be conducted as infection remains the major cause of duodenal ulcers. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Other contributing factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/1\">",
"      Ciociola AA, McSorley DJ, Turner K, et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999; 94:1834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/2\">",
"      Tytgat G, Langenberg W, Rauws E, Rietra P. Campylobacter-like organism (CLO) in the human stomach. Gastroenterology 1985; 88:1620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/3\">",
"      McColl KE, el-Nujumi AM, Chittajallu RS, et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993; 34:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/4\">",
"      Bytzer P, Teglbjaerg PS, Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up. Am J Gastroenterol 2001; 96:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/5\">",
"      Harris AW, Gummett PA, Phull PS, et al. Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output. Aliment Pharmacol Ther 1997; 11:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/6\">",
"      Marshall BJ, McGechie DB, Rogers PA, Glancy RJ. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 1985; 142:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/7\">",
"      Borody TJ, George LL, Brandl S, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991; 86:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/8\">",
"      Dwyer B, Sun NX, Kaldor J, et al. Antibody response to Campylobacter pylori in an ethnic group lacking peptic ulceration. Scand J Infect Dis 1988; 20:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/9\">",
"      Li Z, Zou D, Ma X, et al. Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. Am J Gastroenterol 2010; 105:2570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/10\">",
"      Sipponen P, Varis K, Fr&auml;ki O, et al. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990; 25:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/11\">",
"      Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994; 120:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/12\">",
"      Cullen D, Collins B, Christiansen K. Long term risk of peptic ulcer disease in people with H pylori infection - A community based study. Gastroenterology 1993; 104 (Suppl):A60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/13\">",
"      Leoci C, Ierardi E, Chiloiro M, et al. Incidence and risk factors of duodenal ulcer. A retrospective cohort study. J Clin Gastroenterol 1995; 20:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/14\">",
"      Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/15\">",
"      Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998; 93:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/16\">",
"      el-Omar EM, Penman ID, Ardill JE, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/17\">",
"      el-Omar E, Penman I, Dorrian CA, et al. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/18\">",
"      Peterson WL, Barnett CC, Evans DJ Jr, et al. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol 1993; 88:2038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/19\">",
"      Calam J. The somatostatin-gastrin link of Helicobacter pylori infection. Ann Med 1995; 27:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/20\">",
"      McColl KE. Helicobacter pylori: clinical aspects. J Infect 1997; 34:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/21\">",
"      Harris AW, Gummett PA, Misiewicz JJ, Baron JH. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut 1996; 38:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/22\">",
"      Moss S, Ayesu K, Calam J. Gastrin and gastric acid output one year after eradication of Helicobacter pylori in duodenal ulcer patients. Regul Pept 1991; 35:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/23\">",
"      Gillen D, el-Omar EM, Wirz AA, et al. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology 1998; 114:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/24\">",
"      Moss SF, Legon S, Bishop AE, et al. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/25\">",
"      Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/26\">",
"      Wyatt JI, Rathbone BJ, Dixon MF, Heatley RV. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987; 40:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/27\">",
"      Hogan DL, Rapier RC, Dreilinger A, et al. Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology 1996; 110:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/28\">",
"      Hamlet A, Thoreson AC, Nilsson O, et al. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 1999; 116:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/29\">",
"      Peura DA. Ulcerogenesis: integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer. Am J Gastroenterol 1997; 92:8S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/30\">",
"      Konturek PC, Ernst H, Konturek SJ, et al. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori. Gut 1997; 40:463.",
"     </a>",
"    </li>",
"    <li>",
"     Isenberg J, McQuaid K, Laine L, Walsh J. Acid-Peptic Disorders. In: Textbook of Gastroenterology, 2nd ed, Yamada T (Ed), JP Lippincott, Philadelphia 1995. p.1347.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/32\">",
"      Blaser MJ. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Aliment Pharmacol Ther 1996; 10 Suppl 1:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/33\">",
"      Weel JF, van der Hulst RW, Gerrits Y, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis 1996; 173:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/34\">",
"      Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005; 128:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/35\">",
"      Yamaoka Y. Roles of the plasticity regions of Helicobacter pylori in gastroduodenal pathogenesis. J Med Microbiol 2008; 57:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/36\">",
"      Azuma T, Konishi J, Ito Y, et al. Genetic differences between duodenal ulcer patients who were positive or negative for Helicobacter pylori. J Clin Gastroenterol 1995; 21 Suppl 1:S151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/37\">",
"      Graham DY. Helicobacter pylori and perturbations in acid secretion: the end of the beginning. Gastroenterology 1996; 110:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/38\">",
"      Str&ouml;mberg E, Edebo A, Lundin BS, et al. Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors. Clin Exp Immunol 2005; 140:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/39\">",
"      Cullen DJ, Hawkey GM, Greenwood DC, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997; 41:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/40\">",
"      Martin DF, Montgomery E, Dobek AS, et al. Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease. Am J Gastroenterol 1989; 84:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/41\">",
"      Hawkey CJ. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs. Gut 2000; 46:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/42\">",
"      Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/43\">",
"      Gisbert JP, Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther 2009; 30:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/44\">",
"      McColl KE. How I manage H. pylori-negative, NSAID/aspirin-negative peptic ulcers. Am J Gastroenterol 2009; 104:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/45\">",
"      Chan FK, Sung JJ, Chung SC, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/46\">",
"      Chan FK, To KF, Wu JC, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002; 359:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44679/abstract/47\">",
"      Hawkey CJ, Tulassay Z, Szczepanski L, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention. Lancet 1998; 352:1016.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A392849A5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44679=[""].join("\n");
var outline_f43_40_44679=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H100070473\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EVIDENCE LINKING HELICOBACTER PYLORI TO DUODENAL ULCERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Incidence of H. pylori in patients with duodenal ulcer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      H. pylori occurs before manifestations of the disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Eradication of H. pylori reduces disease recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS OF ULCER FORMATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Increased gastric acid secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Gastric metaplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Immune response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Mucosal defense factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other contributing factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100070473\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/17\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/17|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?7/34/7727\" title=\"algorithm 1\">",
"      Ulcerogenesis with H pylori",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/17|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/24/40333\" title=\"figure 1\">",
"      Acid output and H pylori",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/4/27720?source=related_link\">",
"      Approach to the patient with dyspepsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2634?source=related_link\">",
"      Association between Helicobacter pylori infection and gastrointestinal malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/42/19113?source=related_link\">",
"      Epidemiology and etiology of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12455?source=related_link\">",
"      Management of duodenal ulcers in patients infected with Helicobacter pylori",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/39/24185?source=related_link\">",
"      Metaplastic (chronic) atrophic gastritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/37/6745?source=related_link\">",
"      NSAIDs (including aspirin): Pathogenesis of gastroduodenal toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/44/4809?source=related_link\">",
"      Pathophysiology of and immune response to Helicobacter pylori infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/31/19954?source=related_link\">",
"      Patient information: H. pylori infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?13/58/14242?source=related_link\">",
"      Patient information: Helicobacter pylori infection and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/60/964?source=related_link\">",
"      Patient information: Peptic ulcer disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?5/53/5971?source=related_link\">",
"      Patient information: Peptic ulcers (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/30/29160?source=related_link\">",
"      Physiology of gastric acid secretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/0/19466?source=related_link\">",
"      Unusual causes of peptic ulcer disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_40_44680="Surgical treatment and other localized therapy for metastatic soft tissue sarcoma";
var content_f43_40_44680=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical treatment and other localized therapy for metastatic soft tissue sarcoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Chandrajit P Raut, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Suzanne George, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     George D Demetri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Robert Maki, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Russell S Berman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44680/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/40/44680/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft tissue sarcomas are a heterogeneous group of uncommon tumors arising from mesenchymal cells at all body sites. The malignant precursor cell(s) differentiate along one or several lineages, such as muscle, adipose, fibrous, cartilage, nerve, or vascular tissue. These tumors arise most often in the limbs (particularly the lower extremity), followed in order of frequency by the abdominal",
"    <span class=\"nowrap\">",
"     cavity/retroperitoneum,",
"    </span>",
"    <span class=\"nowrap\">",
"     trunk/thoracic",
"    </span>",
"    region and the head and neck. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227086#H12227086\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227065#H12227065\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While local complications from primary or recurrent sarcomas can cause significant morbidity and occasional mortality, the most life-threatening aspect of sarcomas is their propensity for hematogenous dissemination. The pattern of tumor spread varies according to tumor type:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For most sarcomas of the extremity, chest wall, and head or neck, the primary metastatic site is the lung [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. However, there are exceptions. Extrapulmonary metastases to the retroperitoneum, spine, and paraspinous soft tissues predominate with",
"      <span class=\"nowrap\">",
"       myxoid/round",
"      </span>",
"      cell liposarcomas, although lung metastases develop eventually in almost all [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227107#H12227107\">",
"       \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Pattern of spread'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The primary site of failure is locoregional for retroperitoneal and visceral sarcomas; less commonly, these tumors spread hematogenously to the liver, and also to the lungs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Spread to locoregional lymph nodes is rare (&le;5 percent) with the exception of clear cell and epithelioid sarcomas, angiosarcomas, and rhabdomyosarcomas [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The majority of patients who develop metastatic soft tissue sarcoma are incurable, and palliative systemic treatment is the most appropriate therapy. Judicious use of systemic therapy provides symptom palliation, prevents rapid disease progression, and may, in some cases, prolong survival. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/11/41146?source=see_link\">",
"     \"Systemic treatment of metastatic soft tissue sarcoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, for selected patients, surgical resection of metastatic disease can provide long-term relapse-free survival and potential cure. The majority of these patients have isolated pulmonary metastatic disease.",
"   </p>",
"   <p>",
"    The role of surgery in the treatment of common adult-type metastatic soft tissue sarcomas will be reviewed here. The surgical management of localized primary soft tissue sarcomas of the extremity, trunk, or retroperitoneum, surgical management of specific types of soft tissue sarcoma including gastrointestinal stromal tumors (GIST), rhabdomyosarcoma, uterine sarcomas, desmoids, dermatofibrosarcoma protuberans, and Kaposi's sarcoma, and the general principles of surgical management of pulmonary metastases are discussed elsewhere. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PULMONARY METASTASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete pulmonary metastasectomy is feasible in about one-third of patients presenting with isolated pulmonary metastases from soft tissue sarcoma.",
"   </p>",
"   <p>",
"    As an example, in a single institution series of 719 patients with lung metastases from soft tissue sarcoma, 213 (30 percent) appeared potentially resectable, and 161 (22 percent) were successfully resected with negative margins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Criteria for resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;No single criterion can be reliably used to exclude patients from surgery because of a predictably low likelihood of cure. In general, the inability to achieve a complete resection, a large number of pulmonary nodules, and a short interval between surgical resection of the primary tumor and the development of metastases (less than 12 to 18 months) are adverse prognostic factors for survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. The most important of these is the ability to completely resect all disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. In the setting of asymptomatic disease, surgery in the chest should not be undertaken unless all known deposits of disease are being treated.",
"   </p>",
"   <p>",
"    The following criteria for pulmonary metastasectomy are generally agreed upon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No extrathoracic disease (although this is being challenged [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/10\">",
"       10",
"      </a>",
"      ]), pleural effusion or radiographically suspicious",
"      <span class=\"nowrap\">",
"       hilar/mediastinal",
"      </span>",
"      adenopathy",
"     </li>",
"     <li>",
"      The primary tumor is controlled or controllable",
"     </li>",
"     <li>",
"      The patient is a medically appropriate candidate for intervention and pulmonary resection",
"     </li>",
"     <li>",
"      Complete resection of all disease appears possible",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is no consensus among thoracic surgical oncologists or sarcoma specialists as to what disease burden represents an insurmountable obstacle. Some experts consider resection of more than eight pulmonary nodules to be a futile exercise, whereas other highly experienced referral centers will not uncommonly resect as many lesions as surgically feasible (eg, &gt;50 nodules) in a young, otherwise healthy individual with no evidence of disease elsewhere. It is not clear that such an extensive surgical approach provides long-term benefit to patients, and in our view, resection should be limited to patients with a small number of lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Preoperative staging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most reliable method for assessing metastatic spread is not settled. The majority of pulmonary metastases are detected through helical computed tomography (CT) imaging.",
"   </p>",
"   <p>",
"    Increasingly, integrated",
"    <span class=\"nowrap\">",
"     FDG-PET/CT",
"    </span>",
"    is being used for this purpose, particularly to search for otherwise occult extrathoracic involvement. However, the value over helical CT alone is debated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/11\">",
"     11",
"    </a>",
"    ]. There are several different histologic subtypes of soft tissue sarcoma, many of which are not associated with uptake of the fluorodeoxyglucose (FDG) tracer. Furthermore, in general, extrathoracic metastases are rare for most subtypes (although there are exceptions, see below). Guidelines from the National Comprehensive Cancer Network (NCCN) do not recommend a PET scan in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/12\">",
"     12",
"    </a>",
"    ]. At least some data suggest that PET adds little to diagnostic-quality CT scanning in soft tissue sarcomas of the non-Ewing, non-rhabdomyosarcoma type [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227170#H12227170\">",
"     \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Evaluation for metastatic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, if a PET scan is performed, suspicious positive areas outside of the thorax should be evaluated prior to surgery, due to the possibility of false-positive findings. Confirmation of disease outside of the chest precludes pulmonary metastasectomy, although this tenet is being challenged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/10\">",
"     10",
"    </a>",
"    ]. This subject is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest CT alone is considered the standard staging method at many institutions. Thin-section, high-resolution helical CT is preferred over conventional CT in order to maximize detection of all sites of intrathoracic disease. The presence of bulky mediastinal or hilar nodal disease on CT (which is a rare finding) is considered by most to represent a contraindication to attempted resection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to chest CT, abdomen and pelvic CT is often recommended for patients with",
"    <span class=\"nowrap\">",
"     myxoid/round",
"    </span>",
"    cell liposarcoma, epithelioid sarcoma, angiosarcoma, leiomyosarcoma and sarcomas arising within the abdomen or retroperitoneum to evaluate for intraabdominal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    retroperitoneal metastases. Spine MRI may also be indicated for round cell and",
"    <span class=\"nowrap\">",
"     myxoid/round",
"    </span>",
"    cell liposarcomas which have a propensity to metastasize to the spine and paraspinous soft tissues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Intraoperative staging and resection technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many thoracic surgeons begin the surgical procedure with mediastinoscopy despite the low likelihood of nodal metastases with soft tissue sarcomas (10 percent in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/14\">",
"     14",
"    </a>",
"    ]). Lymph node dissection provides information on staging and prognosis but there is no evidence that this has any clinical impact. Although prognosis is worse compared to no lymph node involvement, the discovery of clinically occult hilar or mediastinal lymph node metastases generally does not change the medical management of these lesions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thoracotomy with wedge resection is the standard procedure for resection; lobectomy or pneumonectomy is rarely necessary. Good results have been obtained with less invasive procedures such as video-assisted thoracoscopy (VATS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/15\">",
"     15",
"    </a>",
"    ]. Although the VATS procedure is oncologically safe and associated with shorter recovery times, one disadvantage is that the surgeon cannot palpate the entire lung in order to discover radiographically occult ipsilateral metastases (",
"    <a class=\"graphic graphic_table graphicRef54065 \" href=\"mobipreview.htm?33/53/34651\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Considering the greater likelihood of leaving behind undetected tumor with VATS as compared to open thoracotomy, the question of whether VATS should be utilized revolves around the natural history of metastatic disease not detected by preoperative CT scan. Some consider thoracoscopic resection to be a valid approach only for patients with a solitary pulmonary nodule because they have a low likelihood of harboring clinically occult metastases. On the other hand, proponents of VATS argue that initially unresected metastases may be resected once they become detectable on surveillance CT scans, without adversely impacting survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no randomized trials addressing this issue. The available retrospective data suggest that patients do at least as well after VATS as after thoracotomy and imply that there is little if any clinical significance to skipped nodules. However, because these favorable outcomes from VATS were obtained predominantly in populations with a limited disease extent, many surgeons restrict VATS to patients with a single or very few pulmonary metastases in the lung periphery. For patients with a limited number of bilateral peripheral lung nodules, staged bilateral VATS procedures may be feasible. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several reports have summarized outcomes of soft tissue sarcoma pulmonary metastasectomy from individual institutions and defined the relevant prognostic factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/1,10,16-21\">",
"     1,10,16-21",
"    </a>",
"    ]. The following illustrates the range of findings from the largest series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a single institution series of 719 patients with pulmonary metastases from soft tissue sarcoma, the median survival for all patients after diagnosis of pulmonary metastases was 15 months, and the three-year survival was 25 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/1\">",
"       1",
"      </a>",
"      ]. Of the patients undergoing complete metastasectomy, the median survival from the time of resection was 33 months, and the three- and five-year survival was 46 and 37 percent, respectively. In contrast, patients who did not undergo resection had a median survival of 11 months and a three-year actuarial survival of 17 percent. A disease-free interval of more than 12 months prior to the development of metastases was a favorable prognostic indicator.",
"     </li>",
"     <li>",
"      The EORTC Soft Tissue and Bone Sarcoma Group conducted a multi-institutional retrospective study of 255 patients who underwent pulmonary metastasectomy for soft tissue sarcoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/17\">",
"       17",
"      </a>",
"      ]. The three- and five-year overall survival rates following metastasectomy were 54 and 38 percent, and the corresponding disease-free survival (DFS) rates were 42 and 35 percent, respectively. Favorable prognostic factors included disease-free interval greater than 2.5 years, microscopically free resection margins, and histologic grade 1 or 2 primary tumors. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=see_link&amp;anchor=H12227065#H12227065\">",
"       \"Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma\", section on 'Introduction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a review of 274 consecutive patients treated at a single institution, the five-year overall survival following pulmonary metastasectomy was approximately 40 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/16\">",
"       16",
"      </a>",
"      ]. Three unfavorable risk factors were identified: metastasis size &gt;2 cm, more than one pulmonary metastasis, and a metastasis-free interval of 18 months or less. Patients with none of these risk factors had a 60 percent five-year survival; the corresponding rates for those with one, two, or three of these factors were 30, 20, and 0 percent, respectively.",
"     </li>",
"     <li>",
"      Long-term outcomes may be less favorable for patients who present with synchronous pulmonary metastases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/20,22\">",
"       20,22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the absence of a randomized trial, it is impossible to know whether these results simply reflect careful patient selection and favorable biology (good performance status and relatively indolent disease progression over time following the discovery of pulmonary metastases) rather than a specific benefit of surgery. However, most lung metastases in soft tissue sarcoma derive from high-grade rather than low-grade histologic subtypes, and the clinical behavior of high-grade sarcomas is generally not indolent. The likelihood of patients with metastatic high grade soft tissue sarcoma surviving five years with no specific therapy is exceedingly low (probably less than 5 percent).",
"   </p>",
"   <p>",
"    There are no data upon which to base a comparison of outcomes in patients treated with surgery versus systemic chemotherapy alone. Many of the surgical series were published at a time when chemotherapy for soft tissue sarcoma was suboptimal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/6\">",
"     6",
"    </a>",
"    ]. Whether the results are still valid in patients treated with modern, histology-based chemotherapy is unknown. However, even with the advances in systemic therapy that have occurred over the last 20 years, the likelihood of five-year survival among patients with metastatic high-grade soft tissue sarcoma is still exceedingly low, probably less than 5 percent.",
"   </p>",
"   <p>",
"    Despite these uncertainties, it is unlikely that clinicians or patients would ever consider a randomized prospective clinical trial (of surgery versus best supportive care or chemotherapy alone) feasible in order to test these hypotheses. Therefore, despite the lack of randomized controlled trials, the retrospective data represent the best available evidence supporting the benefit of surgery as a treatment option for patients with isolated or limited, potentially resectable pulmonary metastases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Adjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with completely resected pulmonary metastases are often referred to medical oncologists to discuss the benefits of postresection chemotherapy. The efficacy of adjuvant chemotherapy in this setting is unproven; there are no randomized controlled trials. Some retrospective reviews indicate better outcome with postoperative adjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/23\">",
"     23",
"    </a>",
"    ], while others do not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/6,24\">",
"     6,24",
"    </a>",
"    ]. The biases inherent in such retrospective reports preclude drawing any definitive conclusions of the benefit of chemotherapy.",
"   </p>",
"   <p>",
"    As a result, the benefit of chemotherapy and its use in this setting remains a matter of clinical judgment weighing a variety of patient-specific variables, such as age, comorbidity, patient preferences, and risk profile, as well as the specific histopathologic subtype of sarcoma involved, and the expected chemosensitivity of the disease. As an example, the rare adult who presents with distant metastases from a primary rhabdomyosarcoma may benefit from postresection combination chemotherapy with or without radiation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/49/34586?source=see_link\">",
"     \"Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, for the more common types of adult soft tissue sarcoma, the role of adjuvant chemotherapy after resection of metastatic disease remains uncertain and cannot be routinely recommended. Guidelines from the National Comprehensive Cancer Network (NCCN) do not make a specific recommendation in this regard, but instead suggest resection of pulmonary metastases \"with or without chemotherapy\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/12\">",
"     12",
"    </a>",
"    ]. Of note, the benefit of adjuvant chemotherapy following resection of earlier stage, localized disease is also controversial and not supported by high-quality evidence. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/11/14521?source=see_link\">",
"     \"Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neoadjuvant chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are theoretical advantages to neoadjuvant chemotherapy, that is chemotherapy administered prior to surgical resection of pulmonary metastases. While there are no data to support a survival benefit from induction chemotherapy as compared to surgery alone, one of the benefits of initial chemotherapy is the ability to assess the efficacy of the specific regimen by evaluation of posttreatment radiographs and the resection specimen. If administration of chemotherapy resulted in a significant response with a high level of tumor necrosis, this might prompt consideration of additional courses of postoperative chemotherapy, if the patient's medical condition can tolerate it. However, there are no data that provide prospective validation of the selective benefit of postoperative chemotherapy in this setting.",
"   </p>",
"   <p>",
"    Perhaps more importantly, patients who rapidly develop extrapulmonary metastases or new lesions in other lung lobes during induction chemotherapy may be spared the morbidity of unnecessary surgery. An alternative strategy is to withhold chemotherapy and simply delay the surgery for six to eight weeks in order to evaluate the natural history of untreated disease through repeat radiographic evaluation.",
"   </p>",
"   <p>",
"    The use of neoadjuvant chemotherapy prior to resection of pulmonary metastases is not a widespread practice, and the decision to pursue this strategy must be made on a case by case basis or in the context of a clinical trial. For most adult-type soft tissue sarcomas, if there are concerns as to the natural history of newly diagnosed untreated metastatic disease, an alternative option is radiographic reassessment of disease status after an interval of six to eight weeks to allow the disease biology to declare itself, and spare patients with aggressive disease unnecessary surgery. The choice of approach may vary significantly depending upon the histologic subtype of the sarcoma, grade, and the symptomatology and performance status of the patient. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Second metastasectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite a potentially curative operation, the majority of patients undergoing pulmonary metastasectomy will suffer a disease relapse. A subset of these patients may be considered for repeat surgical intervention, as long as extrathoracic metastatic disease is absent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Outcomes by histology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The success of this approach in metastatic soft tissue sarcoma is illustrated by the following reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report of 43 patients treated at the National Cancer Institute (NCI), 72 percent could be rendered free of disease at the second thoracotomy, and the median survival for resectable compared to unresectable patients was 25 versus 10 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/26\">",
"       26",
"      </a>",
"      ]. This type of analysis is prone to several sources of bias since the patients who had re-resection might not have been directly comparable to those who did not in terms of disease burden or extent, and performance status. Therefore, it cannot be assumed that the resection procedure itself necessarily improved the outcomes.",
"     </li>",
"     <li>",
"      In a series of 86 patients undergoing reoperation for recurrence of pulmonary metastases, the median disease-specific survival was 43 months, and the estimated five-year survival was 36 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/28\">",
"       28",
"      </a>",
"      ]. Prognostic factors for more favorable outcome included the ability to achieve clear margins, one or two versus three or more nodules, the largest size of metastases &le;2 cm, and low-grade rather than high grade primary tumor histology.",
"     </li>",
"     <li>",
"      The relationship between disease extent at the time of recurrence and outcomes was further shown in a series of 39 patients from M. D. Anderson Cancer Center (MDACC) who underwent reoperation for a second pulmonary metastasis after an initial successful metastasectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/27\">",
"       27",
"      </a>",
"      ]. The median survival for the 19 patients who had complete resection of a single recurrent focus of metastatic disease was 65 months, compared to 14 months for the 15 patients with complete resection of two or more sites of recurrent disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     HEPATIC METASTASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated hepatic metastases may also be amenable to potentially curative resection, although there are fewer available data than with pulmonary metastasectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/29-33\">",
"     29-33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The largest series included 66 patients undergoing hepatic resection",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      open radiofrequency ablation (RFA) for metastatic sarcoma at MDACC between 1996 and 2005 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/32\">",
"       32",
"      </a>",
"      ]. The histology was predominantly GIST (n = 36), but there were 18 leiomyosarcomas, and 12 cases of soft tissue sarcoma, not otherwise specified. Treatment consisted of resection alone in 35, resection plus RFA in 18, and RFA alone in 13. The majority of patients (n = 52) received some form of systemic therapy prior to and following local therapy.",
"      <br/>",
"      <br/>",
"      At a median follow-up of 36 months, 22 remained disease-free. The overall one-, three-, and five-year survival rates were 91, 65, and 27 percent, respectively. The median survival of the patients with GIST who were treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/1/17434?source=see_link\">",
"       imatinib",
"      </a>",
"      was significantly better than that of all the other patients, regardless of histologic subtype or chemotherapy treatment (median survival not reached versus 37.1 months). In this latter group, there were no survivors beyond 58 months. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35386?source=see_link\">",
"       \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Given the highly responsive nature of GISTs to therapy with tyrosine kinase inhibitors such as imatinib, the inclusion of a large number of these patients will skew the results towards a favorable long-term outcomes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/58/34730?source=see_link\">",
"       \"Tyrosine kinase inhibitor therapy for advanced gastrointestinal stromal tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a series of 11 patients undergoing hepatic resection for isolated metastases from leiomyosarcoma (LMS) originating in either the retroperitoneum or gastrointestinal tract, the median survival was 39 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/30\">",
"       30",
"      </a>",
"      ]. Five of six patients undergoing complete resection were alive with a median follow-up of 53 months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9029966\">",
"    <span class=\"h1\">",
"     OTHER THERAPEUTIC OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are some situations in which surgery is not a viable option (eg, due to patient comorbidities) but where there is still the desire to treat a local site of tumor progression. In settings such as these, local interventional therapies are increasingly being used. These include ablation with radiofrequency ablation (RFA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/32,34\">",
"     32,34",
"    </a>",
"    ]), cryoablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/35\">",
"     35",
"    </a>",
"    ], and focal radiation techniques such as stereotactic body radiotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. In addition, for liver metastases, other interventional techniques include hepatic arterial embolization with or without chemotherapy, and radioembolization.",
"   </p>",
"   <p>",
"    These techniques may control a single focus of disease that is progressing while other sites of disease involvement are stable or responding to therapy. However, none of these forms of local therapy have been proven to improve patient survival. Nonsurgical local ablative techniques and stereotactic radiotherapy for the treatment of liver metastases as well as RFA, stereotactic radiotherapy and cryoablation approaches for treatment of lung lesions are discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25255?source=see_link\">",
"     \"Radiofrequency ablation of lung tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/47/17143?source=see_link&amp;anchor=H10#H10\">",
"     \"Stereotactic body radiation therapy for primary and metastatic lung tumors\", section on 'Lung metastases'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20900?source=see_link\">",
"     \"Cryoablation of lung tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/26/16802?source=see_link\">",
"       \"Patient information: Soft tissue sarcoma (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft tissue sarcomas are a heterogeneous group of rare tumors arising from mesenchymal cells at all body sites. For the majority of patients, treatment of metastatic disease is palliative and consists of systemic therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/11/41146?source=see_link\">",
"     \"Systemic treatment of metastatic soft tissue sarcoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, surgical resection of metastatic disease can provide long-term relapse-free survival and the potential for cure in selected patients, the majority of whom have isolated pulmonary metastases. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pulmonary metastasectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For appropriately selected patients with isolated, limited pulmonary metastases from soft tissue sarcoma, we suggest pulmonary metastasectomy rather than palliative systemic chemotherapy alone (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). There is no consensus as to the optimal selection of surgical candidates; however, the following criteria are generally agreed upon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44680/abstract/7\">",
"     7",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H3\">",
"     'Criteria for resection'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No extrathoracic disease, pleural effusion or",
"      <span class=\"nowrap\">",
"       mediastinal/hilar",
"      </span>",
"      adenopathy",
"     </li>",
"     <li>",
"      The primary tumor is controlled or controllable",
"     </li>",
"     <li>",
"      The patient is a medically appropriate candidate for thoracotomy and pulmonary resection",
"     </li>",
"     <li>",
"      Complete resection appears feasible",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is also no consensus among thoracic surgical oncologists or sarcoma specialists as to what disease burden represents an insurmountable obstacle, and this must be decided on a case-by-case basis. In our view, outcomes are best when resection is limited to patients with a small number of pulmonary lesions and at least a 12 to 18 month metastasis-free interval.",
"   </p>",
"   <p>",
"    Issues related to surgical technique and preoperative as well as intraoperative evaluation are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link&amp;anchor=H19#H19\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no evidence to support a survival benefit from adjuvant chemotherapy following complete pulmonary metastasectomy for patients with metastatic soft tissue sarcoma, and we suggest not pursuing this approach outside of the context of a clinical trial (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). An exception to this general rule is rhabdomyosarcoma, for which multimodality treatment is a standard approach, and the role of surgery for metastatic disease is less clear. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Adjuvant chemotherapy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/49/34586?source=see_link\">",
"     \"Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For most patients, we suggest not pursuing neoadjuvant chemotherapy prior to resection of pulmonary metastases (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ), although for certain chemosensitive subtypes of sarcoma, this approach may be reasonable with the goal of gaining a sense of the pace of change of disease and responsiveness to systemic therapy. If there are concerns as to the natural history of newly diagnosed untreated metastatic disease, another option is to reevaluate disease status radiographically after an interval of six to eight weeks. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Neoadjuvant chemotherapy'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=see_link&amp;anchor=H21#H21\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\", section on 'Timing of surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who develop a recurrence of pulmonary metastatic disease, repeat pulmonary resection is reasonable, providing extrathoracic metastatic disease is absent. The decision to pursue a second metastasectomy depends on the disease-free interval, extent of metastatic spread, and evaluation of available systemic therapies which may be relevant to the specific histologic subtype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hepatic metastasectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although far fewer data are available, isolated hepatic metastases may be amenable to resection. There is no consensus as to appropriate eligibility requirements, and the decision to operate must be made on a case by case basis. In addition, as with pulmonary lesions, it is critical to consider the underlying histology of the tumor, the expected natural history, and expected responsiveness to systemic therapy when considering surgery as a component of the treatment plan for metastatic disease. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Hepatic metastases'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other local treatment options",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other local interventional options for limited sites of metastatic disease include radiofrequency ablation, cryoablation, image-guided radiation therapy, and for liver metastases, hepatic arterial embolization with or without chemotherapy, and radioembolization. The role of all of these therapies compared to surgery or chemotherapy remains to be defined. (See",
"    <a class=\"local\" href=\"#H9029966\">",
"     'Other therapeutic options'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/1\">",
"      Billingsley KG, Burt ME, Jara E, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999; 229:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/2\">",
"      Potter DA, Glenn J, Kinsella T, et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 1985; 3:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/3\">",
"      Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 1999; 85:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/4\">",
"      Spillane AJ, Fisher C, Thomas JM. Myxoid liposarcoma--the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol 1999; 6:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/5\">",
"      Mazeron JJ, Suit HD. Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 1987; 60:1800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/6\">",
"      Jablons D, Steinberg SM, Roth J, et al. Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. J Thorac Cardiovasc Surg 1989; 97:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/7\">",
"      McCormack P. Surgical resection of pulmonary metastases. Semin Surg Oncol 1990; 6:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/8\">",
"      Chao C, Goldberg M. Surgical treatment of metastatic pulmonary soft-tissue sarcoma. Oncology (Williston Park) 2000; 14:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/9\">",
"      Quiros RM, Scott WJ. Surgical treatment of metastatic disease to the lung. Semin Oncol 2008; 35:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/10\">",
"      Blackmon SH, Shah N, Roth JA, et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009; 88:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/11\">",
"      Iagaru A, Chawla S, Menendez L, Conti PS. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun 2006; 27:795.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines available online at www.nccn.org (Accessed on July 14, 2011).",
"    </li>",
"    <li>",
"     Roberge D, Hickeson M, Charest M, Turcotte RE. Utility of total body FDG PET/CT imaging in the initial staging of soft-tissue sarcoma (abstract #10531). J Clin Oncol 2009; 27:543s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/14\">",
"      Pfannschmidt J, Klode J, Muley T, et al. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 2006; 81:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/15\">",
"      Gossot D, Radu C, Girard P, et al. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg 2009; 87:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/16\">",
"      Choong PF, Pritchard DJ, Rock MG, et al. Survival after pulmonary metastasectomy in soft tissue sarcoma. Prognostic factors in 214 patients. Acta Orthop Scand 1995; 66:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/17\">",
"      van Geel AN, Pastorino U, Jauch KW, et al. Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer 1996; 77:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/18\">",
"      Frost DB. Pulmonary metastasectomy for soft tissue sarcomas: is it justified? J Surg Oncol 1995; 59:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/19\">",
"      Casson AG, Putnam JB, Natarajan G, et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992; 69:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/20\">",
"      Illuminati G, Ceccanei G, Pacil&egrave; MA, et al. Surgical outcomes for liposarcoma of the lower limbs with synchronous pulmonary metastases. J Surg Oncol 2010; 102:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/21\">",
"      Burt BM, Ocejo S, Mery CM, et al. Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. Ann Thorac Surg 2011; 92:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/22\">",
"      Ferguson PC, Deheshi BM, Chung P, et al. Soft tissue sarcoma presenting with metastatic disease: outcome with primary surgical resection. Cancer 2011; 117:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/23\">",
"      Porter GA, Cantor SB, Walsh GL, et al. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. J Thorac Cardiovasc Surg 2004; 127:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/24\">",
"      Canter RJ, Qin LX, Downey RJ, et al. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis. Cancer 2007; 110:2050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/25\">",
"      Antman K, Crowley J, Balcerzak SP, et al. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. Cancer 1998; 82:1288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/26\">",
"      Pogrebniak HW, Roth JA, Steinberg SM, et al. Reoperative pulmonary resection in patients with metastatic soft tissue sarcoma. Ann Thorac Surg 1991; 52:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/27\">",
"      Casson AG, Putnam JB, Natarajan G, et al. Efficacy of pulmonary metastasectomy for recurrent soft tissue sarcoma. J Surg Oncol 1991; 47:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/28\">",
"      Weiser MR, Downey RJ, Leung DH, Brennan MF. Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg 2000; 191:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/29\">",
"      Yamamoto H, Watanabe K, Nagata M, et al. Surgical treatment for pancreatic metastasis from soft-tissue sarcoma: report of two cases. Am J Clin Oncol 2001; 24:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/30\">",
"      Chen H, Pruitt A, Nicol TL, et al. Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg 1998; 2:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/31\">",
"      Lang H, Nussbaum KT, Kaudel P, et al. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000; 231:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/32\">",
"      Pawlik TM, Vauthey JN, Abdalla EK, et al. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 2006; 141:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/33\">",
"      Chua TC, Chu F, Morris DL. Outcomes of single-centre experience of hepatic resection and cryoablation of sarcoma liver metastases. Am J Clin Oncol 2011; 34:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/34\">",
"      Berber E, Ari E, Herceg N, Siperstein A. Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Surg Endosc 2005; 19:1613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/35\">",
"      Abdalla EK, Pisters PW. Metastasectomy for limited metastases from soft tissue sarcoma. Curr Treat Options Oncol 2002; 3:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/36\">",
"      Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009; 27:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/37\">",
"      Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27:1579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44680/abstract/38\">",
"      Dhakal S, Corbin KS, Milano MT, et al. Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys 2012; 82:940.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7738 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-89.32.226.102-B08792FACF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44680=[""].join("\n");
var outline_f43_40_44680=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PULMONARY METASTASES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Criteria for resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Preoperative staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Intraoperative staging and resection technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Adjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neoadjuvant chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Second metastasectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HEPATIC METASTASES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9029966\">",
"      OTHER THERAPEUTIC OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pulmonary metastasectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hepatic metastasectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other local treatment options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/7738\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/7738|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/53/34651\" title=\"table 1\">",
"      Pulm mets surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/11/14521?source=related_link\">",
"      Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/43/31418?source=related_link\">",
"      Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20900?source=related_link\">",
"      Cryoablation of lung tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35386?source=related_link\">",
"      Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/26/16802?source=related_link\">",
"      Patient information: Soft tissue sarcoma (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/42/25255?source=related_link\">",
"      Radiofrequency ablation of lung tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/49/34586?source=related_link\">",
"      Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/47/17143?source=related_link\">",
"      Stereotactic body radiation therapy for primary and metastatic lung tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/32/13834?source=related_link\">",
"      Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13560?source=related_link\">",
"      Surgical resection of pulmonary metastases: Outcomes by histology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/11/41146?source=related_link\">",
"      Systemic treatment of metastatic soft tissue sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/58/34730?source=related_link\">",
"      Tyrosine kinase inhibitor therapy for advanced gastrointestinal stromal tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_40_44681="Plantar fasciitis and other causes of heel pain";
var content_f43_40_44681=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Plantar fasciitis and other causes of heel pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44681/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44681/contributors\">",
"     Rachelle Buchbinder, MBBS, MSc, PhD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44681/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44681/contributors\">",
"     Zacharia Isaac, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/40/44681/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/40/44681/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/40/44681/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders of the ankle and foot, including ankle sprains, tendinitis, plantar fasciitis, and bursitis, usually occur in association with movement, and they often occur in association with tissue degeneration or result from trauma.",
"   </p>",
"   <p>",
"    Other causes of pain in the foot include stress fractures that occur due to osteoporosis; inflammatory arthritis due to rheumatoid arthritis; the spondyloarthritides, which may also present with an enthesitis (inflammation at tendon insertions into bone); painful peripheral neuropathies (eg, associated with diabetes), which may also predispose to Charcot&rsquo;s joints; improper footwear; movement from a building with wood flooring to one with a concrete slab; prolonged standing; weakness and unsteadiness associated with the problems of aging; and structural disorders such as joint laxity or malalignment of the lower limbs.",
"   </p>",
"   <p>",
"    Painful disorders of the foot will be reviewed here. Tendinitis of the ankle and ankle sprains are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1030?source=see_link\">",
"     \"Posterior and medial ankle tendinopathies not involving the Achilles tendon\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34296?source=see_link\">",
"     \"Ankle sprain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PLANTAR FASCIITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predominant symptom of plantar fasciitis is pain in the plantar region of the foot that is worse when initiating walking. Plantar fasciitis is one of the most common causes of foot pain in adults, estimated to be responsible for about one million patient visits to the doctor per year in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/1\">",
"     1",
"    </a>",
"    ]. The peak incidence occurs between ages 40 and 60 years in the general population, with a younger peak in runners [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. It may be bilateral in up to one-third of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Heel spurs often coexist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]; whether they have a causal role is unknown. They may represent a secondary response to an inflammatory reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The deep plantar fascia (plantar aponeurosis) is a thick, pearly white tissue with longitudinal fibers intimately attached to the skin (",
"    <a class=\"graphic graphic_figure graphicRef61931 \" href=\"mobipreview.htm?19/7/19573\">",
"     figure 1",
"    </a>",
"    ). The central portion is thickest and attaches to the medial process of the tuberosity of the calcaneus; distally, it divides into five slips, one for each toe. The plantar fascia provides support; as the toes extend during the stance phase of gait, it is tightened by a windlass mechanism, resulting in elevation of the longitudinal arch, in inversion of the hindfoot, and in a resultant external rotation of the leg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology is poorly understood and is probably multifactorial. Possible risk factors for the development of plantar fasciitis include obesity, prolonged standing or jumping, flat feet, reduced ankle dorsiflexion, and heel spurs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/3,5,7,9-11\">",
"     3,5,7,9-11",
"    </a>",
"    ]. There is a high incidence in runners, suggesting that plantar fasciitis, at least in this population, is due to an injury caused by repetitive microtrauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/12\">",
"     12",
"    </a>",
"    ]. In this group, the following have been proposed as risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Excessive training (particularly a sudden increase in the distance run)",
"     </li>",
"     <li>",
"      Faulty running shoes",
"     </li>",
"     <li>",
"      Running on unyielding surfaces",
"     </li>",
"     <li>",
"      Flat feet (pes planus or pronated ankles)",
"     </li>",
"     <li>",
"      Limited ankle dorsiflexion (eg, due to a shortened Achilles tendon)",
"     </li>",
"     <li>",
"      Pes cavus (high-arched) foot",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, evidence of an association for most of these factors is limited or absent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plantar fasciitis is common among ballet dancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/17\">",
"     17",
"    </a>",
"    ] and among those performing dance aerobic exercise. Stress applied to the Achilles tendon, due either to muscle contraction or to passive stretching, results in increased tension in the plantar fascia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/18\">",
"     18",
"    </a>",
"    ]. Decreased knee extension, as may occur with tight hamstring muscles, causes an increase in loading of the forefoot when walking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/19\">",
"     19",
"    </a>",
"    ]; this could, in turn, increase the stress on the plantar fascia.",
"   </p>",
"   <p>",
"    Plantar fasciitis usually occurs as an isolated problem but may be associated with systemic rheumatic diseases, particularly reactive arthritis and the spondyloarthritides. Plantar fasciitis has been reported in association with fibromyalgia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/20\">",
"     20",
"    </a>",
"    ] and with fluoride used for the treatment of osteoporosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/21\">",
"     21",
"    </a>",
"    ], and it may be the presenting symptom in patients with nutritional osteomalacia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The site of abnormality is typically near the origin of the plantar fascia at the medial tuberosity of the calcaneum. Specimens of plantar fascia obtained during surgery for plantar fasciitis reveal a spectrum of changes, ranging from degeneration of the fibrous tissue to fibroblastic proliferation, with or without evidence of chronic inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/23-25\">",
"     23-25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A hallmark for diagnosis of plantar fasciitis is local point tenderness. This is best elicited by the examiner dorsiflexing the patient&rsquo;s toes with one hand, in order to pull the plantar fascia taut, and then palpating with the thumb or index finger of the other hand along the fascia from the heel to the forefoot (",
"    <a class=\"graphic graphic_picture graphicRef76161 \" href=\"mobipreview.htm?21/12/21696\">",
"     picture 1",
"    </a>",
"    ). Points of discrete tenderness can be found and marked for possible later injection.",
"   </p>",
"   <p>",
"    Laboratory testing is not helpful in the diagnosis of plantar fasciitis. Tests for inflammation (eg, erythrocyte sedimentation rate and C-reactive protein) will be normal unless there is coexistent inflammatory disease.",
"   </p>",
"   <p>",
"    Radiographic studies may be required to establish the diagnosis when this is in doubt in patients with persistent plantar pain. The primary goal of radiography is to rule out other disorders, especially calcaneal stress fractures. Lateral and axial radiographs are the appropriate views due to the myriad of diagnostic possibilities. The presence of heel spurs is of no diagnostic value in either ruling in or ruling out plantar fasciitis. In one study, 85 percent of 27 patients with plantar fasciitis and 46 percent of 79 controls had calcaneal spurs detected on plain non-weightbearing lateral x-rays read by a radiologist blinded to the clinical diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/26\">",
"     26",
"    </a>",
"    ]. On the other hand, increased plantar fascia thickness and fat pad abnormalities detected in the same x-rays had a sensitivity of 85 percent and a specificity of 95 percent for plantar fasciitis.",
"   </p>",
"   <p>",
"    The soft tissue may be evaluated with magnetic resonance imaging (MRI) in cases resistant to treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/27\">",
"     27",
"    </a>",
"    ]. Features suggestive of plantar fasciitis are thickening of the plantar fascia and increased signal on delayed (T2) and short tau inversion recovery (STIR) images [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/28\">",
"     28",
"    </a>",
"    ]. Technetium scintigraphy has also been successful in localizing the inflammatory focus and in ruling out stress fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasonography of the foot may also be useful in detecting plantar fascial thickening, hypoechogenicity at the insertion upon the calcaneus, blurring of the boundary between fascia and surrounding tissues, and decreased echogenicity suggestive of edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. The sensitivity and specificity of ultrasonography for the diagnosis of plantar fasciitis were 80 percent and 88.5 percent, respectively, in a study of 77 patients and a similar number of asymptomatic controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/32\">",
"     32",
"    </a>",
"    ]. Doppler ultrasound may improve the value of this technique and may provide additional information on local hyperemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plantar heel pain and pain in the sole of the foot may be induced by a number of other disorders. These include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rupture of the plantar fascia &mdash; Rupture of the plantar fascia generally follows physical activity and has a sudden onset, unlike the more gradual appearance of the pain of plantar fasciitis. Examination of the affected foot may reveal a loss of height of the arch. There may be visible swelling, or ecchymosis may be present.",
"     </li>",
"     <li>",
"      Nerve pain due to entrapment &mdash; Entrapment of the posterior tibial nerve as it courses beneath the medial malleolus can cause pain, paresthesia, and numbness on the sole of the foot. Percussion tenderness over the posterior tibial nerve in the tarsal tunnel is characteristically found. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42233?source=see_link&amp;anchor=H27#H27\">",
"       \"Overview of lower extremity peripheral nerve syndromes\", section on 'Tarsal tunnel syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Posterior tibial nerve branch compression and trauma &mdash; Compression or trauma to branches of the posterior tibial nerve, particularly the medial calcaneal branch or to the nerve supplying the abductor digiti quinti can also cause pain in the heel.",
"     </li>",
"     <li>",
"      Bone pain &mdash; Pain arising from the calcaneus may also be associated with exacerbation during weight-bearing. Pain caused by a neoplasm or infection is typically constant or is characterized by nocturnal worsening. Stress fractures should be considered if there has been an increase in physical activity. While plain radiographs may be diagnostic, early changes with infection, tumor, and stress fracture are better differentiated by MRI. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21146?source=see_link\">",
"       \"Overview of cancer pain syndromes\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/34/4649?source=see_link&amp;anchor=H7#H7\">",
"       \"Overview of osteomyelitis in adults\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=see_link\">",
"       \"Overview of stress fractures\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Another cause of calcaneal bone pain is Paget disease, which is generally apparent on plain radiographs with coarsened trabecular bone and which may be accompanied by an elevated serum alkaline phosphatase. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/50/7978?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Paget disease of bone\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tendinitis of the posterior tibialis or flexor digitorum longus tendons &mdash; These typically have an insidious onset with pain and tenderness along the course of the tendons and tendon sheaths. Subtle changes in the position of bones of the midfoot may be indicative of tendon rupture. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1030?source=see_link\">",
"       \"Posterior and medial ankle tendinopathies not involving the Achilles tendon\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Reactive arthritis and other spondyloarthritides &mdash; Asymmetric involvement and a propensity for the joints and entheses of the lower extremities are frequently seen in the spondyloarthritides. Back pain with inflammatory features (eg, night pain, prolonged morning stiffness) is frequently present in patients with ankylosing spondylitis, while a prior history of enterocolitis or of genitourinary infection is suggestive of reactive arthritis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33210?source=see_link\">",
"       \"Reactive arthritis (formerly Reiter syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Painful heel pad syndrome &mdash; The painful heel pad syndrome most often occurs in marathon runners. It is thought to result from disruption of the fibrous septae that compartmentalize the fat in the heel pad. Pain is localized to the heel pad. The plantar fascia is not tender, and pain is not accentuated as the examiner dorsiflexes the toes. Insertion of heel cups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/37\">",
"       37",
"      </a>",
"      ] and &ldquo;plastazote&rdquo; that is individually molded to the patient&rsquo;s heel may be useful [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Atrophy of the heel pad &mdash; Atrophy of the heel pad occurs in older adults. Palpation reveals bony prominence without the padding usually afforded by subcutaneous fat. Unlike pain due to plantar fasciitis, pain due to atrophy of the heel pad is absent in the morning, and it develops and worsens during weight-bearing throughout the day.",
"     </li>",
"     <li>",
"      Piezogenic papules &mdash; Piezogenic papules are herniations of fat that occur as painful papules at the medial inferior border of the heel. They may be noted only upon weight-bearing and are an uncommon cause of painful heels. Weight reduction, use of felt padding, and cushion-soled or crepe-soled shoes may provide relief [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sarcoidosis &mdash; Heel pain has been reported to occur in sarcoidosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/40\">",
"       40",
"      </a>",
"      ]. The combination of erythema nodosum, hilar adenopathy, migratory polyarthralgia, and fever is referred to as Lofgren&rsquo;s syndrome and is typically seen in patients with sarcoidosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13130?source=see_link\">",
"       \"Erythema nodosum\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43544748\">",
"    <span class=\"h3\">",
"     Approach to therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We generally take the following initial measures (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Initial therapy'",
"    </a>",
"    below):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Performing of stretching exercises for the plantar fascia and calf muscles, which the patient can do at home",
"     </li>",
"     <li>",
"      Avoiding the use of flat shoes and barefoot walking",
"     </li>",
"     <li>",
"      Using prefabricated, over-the-counter, silicone heel shoe inserts (arch supports",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      heel cups)",
"     </li>",
"     <li>",
"      Decreasing physical activities that are suggested by the medical history to be causative or aggravating (eg, excessive running, dancing, or jumping)",
"     </li>",
"     <li>",
"      Prescribing or recommending a short-term trial (two to three weeks) of nonsteroidal antiinflammatory drugs (NSAIDs). Use of NSAIDs is reasonable, but their long-term use should be reserved for patients with known systemic rheumatic disease.",
"     </li>",
"     <li>",
"      Injecting the tender areas of the plantar region with glucocorticoids and a local anesthetic",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients without sufficient improvement from initial measures, more costly therapies can be considered, although these remain unproven (see",
"    <a class=\"local\" href=\"#H43544846\">",
"     'Resistant disease'",
"    </a>",
"    below):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Molded shoe inserts (orthotics)",
"     </li>",
"     <li>",
"      Night splints",
"     </li>",
"     <li>",
"      Immobilization with a cast",
"     </li>",
"     <li>",
"      Extracorporeal shock wave therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Surgery is generally reserved for those patients who do not respond to at least 6 to 12 months of conservative therapy. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Surgical therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Initial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of obesity, symptomatic flat feet, and systemic inflammation should be undertaken when these conditions are present. Otherwise, treatment should begin with conservative therapy including measures to relieve pain, alterations in shoes or habits, and exercise therapy. It should be noted that there are limited data for the effectiveness of most of these modalities in the treatment of plantar fasciitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/34,41\">",
"     34,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rest and icing may give initial pain relief.",
"     </li>",
"     <li>",
"      Nonsteroidal antiinflammatory drugs (NSAIDs) are often used. A well-designed but small trial that randomly assigned 29 patients to NSAID or to placebo reported a nonsignificant trend toward improved pain and disability in the NSAID group [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/42\">",
"       42",
"      </a>",
"      ]. Use for longer than two or three weeks should be reserved for patients with systemic inflammation.",
"     </li>",
"     <li>",
"      There are conflicting reports on the benefit of resting padded foot splints [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/43-46\">",
"       43-46",
"      </a>",
"      ]; these splints can usually be purchased in pharmacies that feature orthopedic supplies (",
"      <a class=\"graphic graphic_picture graphicRef63789 \" href=\"mobipreview.htm?26/40/27279\">",
"       picture 2",
"      </a>",
"      ). The splints are worn at night to keep the ankle in the neutral position with or without dorsiflexion of the metatarsophalangeal joints during sleep. A clinical trial reported they were of similar effectiveness to custom-fitted orthotics (see below), although there was better compliance, as well as fewer side effects, reported with orthoses use [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prefabricated silicone heel inserts combined with stretching exercises (see below) may be of value [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/48\">",
"       48",
"      </a>",
"      ]. Felt pads or rubber heel cups appear to be less effective than silicone inserts; magnetic insoles have not been found to provide additional benefit compared with nonmagnetic insoles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/49,50\">",
"       49,50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Wearing slippers or going barefoot may aggravate symptoms or may result in a recurrence of symptoms. Thus, the first step out of bed should be made wearing a supportive shoe or sandal.",
"     </li>",
"     <li>",
"      Patients who work or reside in buildings with concrete floors should use cushion-soled or crepe-soled shoes. Excessive heel impact from jumping, excessive heel impact during walking, or use of a trampoline should be avoided.",
"     </li>",
"     <li>",
"      Athletic shoes, arch-supporting shoes (particularly those with an extra-long counter, which is the firm part of the shoe that surrounds the heel), or shoes with rigid shanks (usually a metal insert into the sole of the shoe) may be helpful. Shoes with these features can be found in stores featuring work shoes or &ldquo;orthopedic shoes.&rdquo;",
"     </li>",
"     <li>",
"      Exercises may be beneficial, although evidence is limited. Home exercises include the calf-plantar fascia stretch (",
"      <a class=\"graphic graphic_picture graphicRef82144 \" href=\"mobipreview.htm?11/28/11712\">",
"       picture 3",
"      </a>",
"      ), foot-ankle circles (",
"      <a class=\"graphic graphic_picture graphicRef70569 \" href=\"mobipreview.htm?20/9/20627\">",
"       picture 4",
"      </a>",
"      ), toe curls (",
"      <a class=\"graphic graphic_picture graphicRef56422 \" href=\"mobipreview.htm?0/29/468\">",
"       picture 5",
"      </a>",
"      ), and toe towel curls (",
"      <a class=\"graphic graphic_picture graphicRef70243 \" href=\"mobipreview.htm?20/60/21442\">",
"       picture 6",
"      </a>",
"      ). One unblinded trial noted that non-weightbearing stretching exercises specific to the plantar fascia were more beneficial in the short term than weightbearing Achilles tendon-stretching exercises [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/51\">",
"       51",
"      </a>",
"      ], although the method of analysis may have biased toward this result. At two-year follow-up, there were no differences between groups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/52\">",
"       52",
"      </a>",
"      ]. Another placebo-controlled trial found no significant differences in pain and function in those who undertook a two-week calf muscle stretching program compared with those who did not [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/53\">",
"       53",
"      </a>",
"      ]. Ultrasound therapy, ice massage, and deep friction massage may be used prior to exercise, although their effectiveness is unknown.",
"     </li>",
"     <li>",
"      Tape support of the affected plantar surface, a technique referred to as low-Dye taping, may be beneficial to some patients particularly for first-step pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. Four strips of tape are applied in a specific fashion to provide such support (",
"      <a class=\"graphic graphic_picture graphicRef70684 \" href=\"mobipreview.htm?17/12/17603\">",
"       picture 7",
"      </a>",
"      ). The tape should not be applied too tightly, and use of hypoallergenic tape is recommended to avoid allergic reactions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If these inexpensive and noninvasive measures fail to bring about improvement within two to three weeks, a trial of a glucocorticoid injection or other alternative approaches may be of benefit.",
"   </p>",
"   <p>",
"    The points of tenderness along the plantar fascia may be injected with a glucocorticoid and local anesthetic mixture (",
"    <a class=\"graphic graphic_picture graphicRef61694 \" href=\"mobipreview.htm?17/16/17679\">",
"     picture 8",
"    </a>",
"    ). Injections may provide short-term, temporary pain relief. In a randomized trial involving 106 patients, significantly less pain was noted in patients who received a single injection of 1 mL each of glucocorticoid and local anesthetic (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    ) than in those who received an injection of 2 mL of local anesthetic alone, a difference that was significant at one month but not at three or six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/56\">",
"     56",
"    </a>",
"    ]. In one non-randomized trial in which four types of injections were compared (25 consecutive patients in each group), those who received glucocorticoid (2 mL of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/38/39520?source=see_link\">",
"     triamcinolone",
"    </a>",
"    ) either as a single injection or using a peppering technique were reported to have better outcomes than those who received either 2 mL autologous blood or 2 mL lidocaine using a peppering technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative and possibly less painful approach, a medial injection, may also provide significant benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/58\">",
"     58",
"    </a>",
"    ]. While the author uses a single injection directed to the site of maximal tenderness, other approaches include injections into more than one tender location along the fascia. The utility of using ultrasound to guide placement of the injection remains uncertain. Two randomized trials have found that pain relief from ultrasound-guided injection was no different to blind injection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/59,60\">",
"     59,60",
"    </a>",
"    ] although one trial reported a lower recurrence rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Glucocorticoid injection should be used judiciously since repeated injection may cause heel pad atrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/61\">",
"     61",
"    </a>",
"    ]. It may also predispose to plantar fascia rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/62,63\">",
"     62,63",
"    </a>",
"    ], although evidence for this is limited and nonconclusive. One study reported a series of 37 patients with a presumptive diagnosis of plantar fascia rupture, all of whom had had a prior episode of plantar fasciitis treated with glucocorticoid injection into the calcaneal origin of the fascia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/62\">",
"     62",
"    </a>",
"    ]. In another study of 765 patients with plantar fasciitis, 43 of 51 patients with plantar fascia rupture had received one or more glucocorticoid injections, although the number of patients without plantar fascial rupture who received one or more glucocorticoid injections was not reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A randomized trial of glucocorticoid injection compared with extracorporeal shock wave therapy (see",
"    <a class=\"local\" href=\"#H43544846\">",
"     'Resistant disease'",
"    </a>",
"    below) in 132 patients found that, after three months, there was significantly less pain in those who received the injection (mean differences in visual analogue pain of 1.48 and 3.69, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Injection of autologous blood has been proposed as a treatment for plantar fasciitis on the basis that it may begin a cascade of local factors to stimulate angiogenesis and healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/65\">",
"     65",
"    </a>",
"    ]. While no trials have assessed the efficacy of autologous blood injection compared with placebo for plantar fasciitis, two trials have compared this treatment with glucocorticoid injection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/57,65\">",
"     57,65",
"    </a>",
"    ]. While participants improved over time irrespective of treatment received, both trials reported significant differences in benefit favoring the glucocorticoid groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/57,65\">",
"     57,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other potential measures include custom orthotics or a trial of iontophoresis therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Custom-fabricated inserts, usually provided by podiatrists, include inserted orthoses with foam rubber raised arches and rubber or tub heels, as well as molded ankle-foot orthoses. A Cochrane systematic review that identified five trials including 691 participants that assessed the use of custom-made foot orthoses for plantar fasciitis was inconclusive [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/66\">",
"       66",
"      </a>",
"      ].Comparators varied across trials and included sham orthoses, no treatment, non-custom foot orthoses, night splints, and a combination of manipulation, mobilization, and stretching; all trials were judged to be at high risk of bias. All but one trial reported comparable outcomes between treatment groups. One trial found better functional outcomes but comparable pain relief with use of custom-made foot orthoses compared with sham orthoses at 3 and 12 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/67\">",
"       67",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The efficacy of foot orthoses remains controversial, and there are considerable variations in the prescribing habits of podiatrists, orthopedists, and prosthetists [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/67-69\">",
"       67-69",
"      </a>",
"      ]. Any potential advantage of customized orthotics over prefabricated ones must be weighed against a substantial difference in cost, estimated to be approximately twofold to sixfold more for the customized version [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/67\">",
"       67",
"      </a>",
"      ]. A short walking cast is used by some orthopedists, though, again, there are no published trials of this treatment approach.",
"     </li>",
"     <li>",
"      Iontophoresis with 0.4 percent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      (six sessions over two weeks) provided moderate initial relief of plantar pain in a small, randomized, placebo-controlled trial in runners with plantar fasciitis, although this effect was not maintained at four weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/70\">",
"       70",
"      </a>",
"      ]. In another small study, low-Dye taping combined with iontophoresis with a 5 percent solution of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19011?source=see_link\">",
"       acetic acid",
"      </a>",
"      was superior to taping and iontophoresis with 0.4 percent dexamethasone but was comparable in benefit to taping and iontophoresis with placebo (in place of either acetic acid or dexamethasone) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43544846\">",
"    <span class=\"h3\">",
"     Resistant disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several approaches that may be helpful in patients without sufficient improvement from initial measures, but these approaches are generally more costly and are of uncertain benefit. These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Shock wave therapy",
"      </strong>",
"      &mdash; The effectiveness of extracorporeal shock wave therapy for plantar fasciitis has been more extensively studied than any other single treatment modality. A number of randomized trials have compared shock wave therapy with either placebo or sub-therapeutic doses of shock waves [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/72-74\">",
"       72-74",
"      </a>",
"      ]. These trials have been of variable methodological quality and have reported conflicting results. A systematic review published in 2005 included 11 trials and performed a pooled analysis of data from six trials involving 897 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/72\">",
"       72",
"      </a>",
"      ]. The authors concluded that there was no clinically important benefit of shock wave therapy despite a small statistically significant benefit in morning pain of less than 0.5 cm on a 10 cm visual analogue scale. No statistically significant benefit was observed in a sensitivity analysis that only included high-quality trials. A subsequent trial of a pneumatic low-energy extracorporeal shock wave device also reported that outcomes from shock wave treatment were no better than sham therapy in a trial of 25 participants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/75\">",
"       75",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      There is ongoing clinical uncertainty about the effectiveness of shock wave therapy; opinions are highly polarized, fueled by the lack of convergence of findings from randomized evaluations. Explanations that have been put forward to explain the differing results include variation in methodological quality, the different types of equipment that have been used to generate the shock waves, different delivery methods, and different doses. Duration of symptoms has not been found to influence response to treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/76,77\">",
"       76,77",
"      </a>",
"      ]. An association between therapeutic response and the amount of the shock wave energy applied was noted in one study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/74\">",
"       74",
"      </a>",
"      ]. The major reported adverse effect is transient pain at the time of treatment.",
"     </li>",
"     <li>",
"      <strong>",
"       Botulinum toxin injection",
"      </strong>",
"      &mdash; A single, small, randomized trial of 27 patients with unilateral or bilateral plantar fasciitis assessed the effect of two injections of botulinum toxin (total of 70 units), one into the foot near the calcaneal tuberosity (40 units) and the other into the arch (30 units) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/78\">",
"       78",
"      </a>",
"      ]. Feet injected with botulinum toxin had more improvement in pain and tenderness at three and eight weeks than those injected with saline solution (placebo), although effect sizes were not reported. Another randomized trial found comparable benefit of botulinum injection or glucocorticoid injection for plantar fasciitis at one month [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/79\">",
"       79",
"      </a>",
"      ]. Further trials are needed before considering this treatment approach for usual care.",
"     </li>",
"     <li>",
"      <strong>",
"       Complementary therapies",
"      </strong>",
"      &mdash; Topical application of wheatgrass cream twice daily for six weeks was ineffective when compared with placebo in a randomized trial involving 80 participants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/80\">",
"       80",
"      </a>",
"      ]. Other trials of complementary therapies are expected.",
"     </li>",
"     <li>",
"      <strong>",
"       Radiotherapy",
"      </strong>",
"      &mdash; Radiation therapy is sometimes used in Europe to treat chronic plantar fasciitis that is unresponsive to more conservative approaches [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/81\">",
"       81",
"      </a>",
"      ]. Its effectiveness has not been assessed in randomized controlled trials, and whether there is a long-term increased risk of carcinogenesis is unknown. Because of concern about the possibility of late onset hematopoietic malignancy, radiation therapy is seldom used to treat plantar fasciitis in other parts of the world.",
"      <br/>",
"      <br/>",
"      A survey of German radiation treatment institutions found that 81 percent provided radiation therapy for heel pain associated with calcaneal spurs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/81\">",
"       81",
"      </a>",
"      ]. There was wide variation in the amount of radiation delivered per session (median 1 Gy) and in the total amount of radiation (median 6 Gy). Retrospective review of the outcomes of a single course of therapy in 7947 patients at 76 centers found that complete pain relief lasting at least three months occurred in 25 to 100 percent of patients (median 70 percent) and was not related to the dose of radiation delivered. Approximately 15 percent of treatment courses resulted in no pain relief.",
"     </li>",
"     <li>",
"      <strong>",
"       Cryosurgery",
"      </strong>",
"      &mdash; A single-arm study that used percutaneous cryosurgery, a minimally invasive technique for freezing tissue, to treat plantar fasciitis in 59 patients reported a benefit at one year but did not report earlier outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/82\">",
"       82",
"      </a>",
"      ]. The effectiveness of this technique needs to be assessed in controlled trials.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Surgical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of patients with plantar fasciitis will improve without surgery. It is estimated that 2 to 5 percent of patients with plantar fasciitis undergo surgical procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/2,4,12,83\">",
"     2,4,12,83",
"    </a>",
"    ], although the rate may be much lower. As an example, a report of the surgical experience at the Mayo Clinic found that only 16 operations had been performed during a 12-year study period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/84\">",
"     84",
"    </a>",
"    ]. Combining release of the plantar fascia and the first branch of the lateral plantar nerve may enhance results. In one series of 28 patients (33 feet), over 90 percent of patients had a good outcome and would recommend the procedure to others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While numerous surgical procedures have been described, none have been assessed in controlled trials. Favorable outcomes are reported in more than 75 percent of published case series, although recovery time may be prolonged and although persistent pain is not uncommon. Variations of open or closed, partial or complete, plantar fascia release with or without calcaneal spur resection, excision of abnormal tissue, and nerve decompression have been described.",
"   </p>",
"   <p>",
"    In comparison with open-release, closed procedures may allow more rapid recovery and resumption of usual activities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. In an uncontrolled series of 16 runners and 10 walkers with refractory plantar fasciitis, uniportal plantar fasciotomy gave good or excellent results, provided that the patient&rsquo;s body mass index was less than 27 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/88\">",
"     88",
"    </a>",
"    ]. Runners in this series required a mean of 2.6 months before returning to jogging.",
"   </p>",
"   <p>",
"    Potential complications of surgery include transient heel pad swelling, calcaneal fracture injury to the posterior tibial nerve or its branches, and flattening of the longitudinal arch with resultant midtarsal pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of preventive strategies, such as stretching exercises and control of the intensity of running (eg distance, frequency, and duration), in specifically preventing plantar fasciitis is unknown [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/89\">",
"     89",
"    </a>",
"    ]. Footwear designed to maximize shock absorption may be of value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcome for patients with plantar fasciitis is generally favorable; approximately 80 percent of patients have complete resolution of pain within one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/4,83,91,92\">",
"     4,83,91,92",
"    </a>",
"    ]. The favorable natural history of this benign condition should be borne in mind when weighing the potential benefits and risks of unproven and sometimes costly treatments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     OTHER CAUSES OF HEEL PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of other disorders may cause heel pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8674983\">",
"    <span class=\"h2\">",
"     Achilles tendinopathy or tendonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disorders of the Achilles tendon typically produce posterior heel pain. Achilles tendinopathy and its management are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32537?source=see_link\">",
"     \"Achilles tendinopathy and tendon rupture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Haglund's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prominent, enlarged, bony, posterior-superior calcaneal tubercle sometimes causes compression of soft tissue and foot pain (which may be due, in part, to a retrocalcaneal bursitis) in the posterior area of the heel over the bony prominence, above the site of attachment of the Achilles tendon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/93\">",
"     93",
"    </a>",
"    ]. Patients with this syndrome, termed Haglund&rsquo;s syndrome or posterior calcaneal tubercle impingement syndrome, may report discomfort when wearing shoes and may have a palpable 2 to 3 mm bony extrusion with an area of erythema and swelling of the overlying skin.",
"   </p>",
"   <p>",
"    Treatments include a well-fitted heel cup, a laced or strapped shoe that reduces heel counter friction, and heel padding to raise the heel, although none of these have been subject to randomized trials. Surgical excision may be considered if the exostosis is large and if symptoms persist, but recovery time may be prolonged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/40/44681/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Calcaneal spurs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcaneal spurs can develop on the plantar tuberosity and can extend across the entire width of the calcaneus. The apex of the spur is embedded in the plantar fascia. Heel spurs are typically asymptomatic (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58778 \" href=\"mobipreview.htm?27/51/28478\">",
"     image 1",
"    </a>",
"    ), and surgery is rarely, if ever, necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/5/40018?source=see_link\">",
"       \"Patient information: Heel pain (caused by plantar fasciitis) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/42/38561?source=see_link\">",
"       \"Patient information: Heel pain (caused by plantar fasciitis) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16389916\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plantar fasciitis is a painful disorder that is associated with degenerative and sometimes chronic inflammatory changes in the affected tissue. It has a good prognosis, and patients can be informed that, with conservative treatment, most will enjoy complete resolution of symptoms within one year. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many types of treatments have been used for plantar fasciitis, but few have been rigorously validated in large clinical trials. Based upon the data presented in this review, the following initial interventions are recommended (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Performing of stretching exercises for the plantar fascia and calf muscles, which the patient can do at home",
"     </li>",
"     <li>",
"      Avoiding the use of unsupportive shoes and barefoot walking",
"     </li>",
"     <li>",
"      Using prefabricated, over-the-counter, shoe inserts",
"     </li>",
"     <li>",
"      Decreasing physical activities that aggravate symptoms",
"     </li>",
"     <li>",
"      Prescribing or recommending a short-term trial (two to three weeks) of NSAIDs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients in whom initial measures are ineffective within two to three months, a single glucocorticoid injection may be administered. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Initial therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with plantar fasciitis in whom the treatments above have not produced sufficient improvement, more costly therapies can be considered, such as molded shoe inserts (orthotics), especially in the setting of clinical malalignment; night splints; and immobilization in a cushioned walking boot. However, the benefit of these approaches remains unproven. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Initial therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgery for plantar fasciitis is generally reserved for those patients who do not respond to at least 6 to 12 months of nonoperative therapy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Surgical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of heel pain include Achilles tendinopathy and Haglund&rsquo;s syndrome. Calcaneal bone spurs are generally asymptomatic. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Other causes of heel pain'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16389923\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editors of UpToDate, Inc. would like to acknowledge Robert P Sheon, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/1\">",
"      Riddle DL, Schappert SM. Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis: a national study of medical doctors. Foot Ankle Int 2004; 25:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/2\">",
"      Furey JG. Plantar fasciitis. The painful heel syndrome. J Bone Joint Surg Am 1975; 57:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/3\">",
"      Taunton JE, Ryan MB, Clement DB, et al. A retrospective case-control analysis of 2002 running injuries. Br J Sports Med 2002; 36:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/4\">",
"      LAPIDUS PW, GUIDOTTI FP. PAINFUL HEEL: REPORT OF 323 PATIENTS WITH 364 PAINFUL HEELS. Clin Orthop Relat Res 1965; 39:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/5\">",
"      Sadat-Ali M. Plantar fasciitis/calcaneal spur among security forces personnel. Mil Med 1998; 163:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/6\">",
"      Onuba O, Ireland J. Plantar fasciitis. Ital J Orthop Traumatol 1986; 12:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/7\">",
"      Prichasuk S, Subhadrabandhu T. The relationship of pes planus and calcaneal spur to plantar heel pain. Clin Orthop Relat Res 1994; :192.",
"     </a>",
"    </li>",
"    <li>",
"     Essentials of Musculoskeletal Care, 2nd, Greene WB (Ed), American Academy of Orthopaedic Surgeons, Rosemont 2001. p.487.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/9\">",
"      Riddle DL, Pulisic M, Pidcoe P, Johnson RE. Risk factors for Plantar fasciitis: a matched case-control study. J Bone Joint Surg Am 2003; 85-A:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/10\">",
"      Gill LH, Kiebzak GM. Outcome of nonsurgical treatment for plantar fasciitis. Foot Ankle Int 1996; 17:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/11\">",
"      Rano JA, Fallat LM, Savoy-Moore RT. Correlation of heel pain with body mass index and other characteristics of heel pain. J Foot Ankle Surg 2001; 40:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/12\">",
"      McBryde AM Jr. Plantar fasciitis. Instr Course Lect 1984; 33:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/13\">",
"      Warren BL, Jones CJ. Predicting plantar fasciitis in runners. Med Sci Sports Exerc 1987; 19:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/14\">",
"      Rome K. Anthropometric and biomechanical risk factors in the development of plantar heel pain - a review of the literature. Phys Ther Rev 1997; 2:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/15\">",
"      Messier SP, Pittala KA. Etiologic factors associated with selected running injuries. Med Sci Sports Exerc 1988; 20:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/16\">",
"      Warren BL. Anatomical factors associated with predicting plantar fasciitis in long-distance runners. Med Sci Sports Exerc 1984; 16:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/17\">",
"      Oloff LM, Schulhofer SD. Flexor hallucis longus dysfunction. J Foot Ankle Surg 1998; 37:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/18\">",
"      Cheung JT, Zhang M, An KN. Effect of Achilles tendon loading on plantar fascia tension in the standing foot. Clin Biomech (Bristol, Avon) 2006; 21:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/19\">",
"      Harty J, Soffe K, O'Toole G, Stephens MM. The role of hamstring tightness in plantar fasciitis. Foot Ankle Int 2005; 26:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/20\">",
"      Harvey CK. Fibromyalgia. Part II. Prevalence in the podiatric patient population. J Am Podiatr Med Assoc 1993; 83:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/21\">",
"      Riggs BL, Hodgson SF, Hoffman DL, et al. Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA 1980; 243:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/22\">",
"      Paice EW, Hoffbrand BI. Nutritional osteomalacia presenting with plantar fasciitis. J Bone Joint Surg Br 1987; 69:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/23\">",
"      Jarde O, Diebold P, Havet E, et al. Degenerative lesions of the plantar fascia: surgical treatment by fasciectomy and excision of the heel spur. A report on 38 cases. Acta Orthop Belg 2003; 69:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/24\">",
"      Leach RE, Seavey MS, Salter DK. Results of surgery in athletes with plantar fasciitis. Foot Ankle 1986; 7:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/25\">",
"      Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc 2003; 93:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/26\">",
"      Osborne HR, Breidahl WH, Allison GT. Critical differences in lateral X-rays with and without a diagnosis of plantar fasciitis. J Sci Med Sport 2006; 9:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/27\">",
"      Helie O, Dubayle P, Boyer B, Pharaboz C. [Magnetic resonance imaging of lesions of the superficial plantar fasciitis]. J Radiol 1995; 76:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/28\">",
"      McGonagle D, Marzo-Ortega H, O'Connor P, et al. The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 2002; 46:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/29\">",
"      Dasgupta B, Bowles J. Scintigraphic localisation of steroid injection site in plantar fasciitis. Lancet 1995; 346:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/30\">",
"      Gibbon WW, Long G. Ultrasound of the plantar aponeurosis (fascia). Skeletal Radiol 1999; 28:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/31\">",
"      Groshar D, Alperson M, Toubi A, et al. Plantar fasciitis: detection with ultrasonography versus bone scintigraphy. The Foot 2000; 10:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/32\">",
"      Sabir N, Demirlenk S, Yagci B, et al. Clinical utility of sonography in diagnosing plantar fasciitis. J Ultrasound Med 2005; 24:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/33\">",
"      Walther M, Radke S, Kirschner S, et al. Power Doppler findings in plantar fasciitis. Ultrasound Med Biol 2004; 30:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/34\">",
"      Buchbinder R. Clinical practice. Plantar fasciitis. N Engl J Med 2004; 350:2159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/35\">",
"      Cole C, Seto C, Gazewood J. Plantar fasciitis: evidence-based review of diagnosis and therapy. Am Fam Physician 2005; 72:2237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/36\">",
"      Singh D, Angel J, Bentley G, Trevino SG. Fortnightly review. Plantar fasciitis. BMJ 1997; 315:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/37\">",
"      Katoh Y, Chao EY, Morrey BF, Laughman RK. Objective technique for evaluating painful heel syndrome and its treatment. Foot Ankle 1983; 3:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/38\">",
"      Spiegl PV, Johnson KA. Heel pain syndrome: Which treatments to choose? J Musculoskel Med 1984; 1:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/39\">",
"      Shelley WB, Rawnsley HM. Painful feet due to herniation of fat. JAMA 1968; 205:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/40\">",
"      Shaw RA, Holt PA, Stevens MB. Heel pain in sarcoidosis. Ann Intern Med 1988; 109:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/41\">",
"      Crawford F, Thomson C. Interventions for treating plantar heel pain. Cochrane Database Syst Rev 2003; :CD000416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/42\">",
"      Donley BG, Moore T, Sferra J, et al. The efficacy of oral nonsteroidal anti-inflammatory medication (NSAID) in the treatment of plantar fasciitis: a randomized, prospective, placebo-controlled study. Foot Ankle Int 2007; 28:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/43\">",
"      Powell M, Post WR, Keener J, Wearden S. Effective treatment of chronic plantar fasciitis with dorsiflexion night splints: a crossover prospective randomized outcome study. Foot Ankle Int 1998; 19:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/44\">",
"      Probe RA, Baca M, Adams R, Preece C. Night splint treatment for plantar fasciitis. A prospective randomized study. Clin Orthop Relat Res 1999; :190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/45\">",
"      Ryan J. Use of posterior night splints in the treatment of plantar fasciitis. Am Fam Physician 1995; 52:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/46\">",
"      Wapner KL, Sharkey PF. The use of night splints for treatment of recalcitrant plantar fasciitis. Foot Ankle 1991; 12:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/47\">",
"      Roos E, Engstr&ouml;m M, S&ouml;derberg B. Foot orthoses for the treatment of plantar fasciitis. Foot Ankle Int 2006; 27:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/48\">",
"      Pfeffer G, Bacchetti P, Deland J, et al. Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int 1999; 20:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/49\">",
"      Caselli MA, Clark N, Lazarus S, et al. Evaluation of magnetic foil and PPT Insoles in the treatment of heel pain. J Am Podiatr Med Assoc 1997; 87:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/50\">",
"      Winemiller MH, Billow RG, Laskowski ER, Harmsen WS. Effect of magnetic vs sham-magnetic insoles on plantar heel pain: a randomized controlled trial. JAMA 2003; 290:1474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/51\">",
"      DiGiovanni BF, Nawoczenski DA, Lintal ME, et al. Tissue-specific plantar fascia-stretching exercise enhances outcomes in patients with chronic heel pain. A prospective, randomized study. J Bone Joint Surg Am 2003; 85-A:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/52\">",
"      Digiovanni BF, Nawoczenski DA, Malay DP, et al. Plantar fascia-specific stretching exercise improves outcomes in patients with chronic plantar fasciitis. A prospective clinical trial with two-year follow-up. J Bone Joint Surg Am 2006; 88:1775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/53\">",
"      Radford JA, Landorf KB, Buchbinder R, Cook C. Effectiveness of calf muscle stretching for the short-term treatment of plantar heel pain: a randomised trial. BMC Musculoskelet Disord 2007; 8:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/54\">",
"      Landorf KB, Radford JA, Keenan AM, Redmond AC. Effectiveness of low-Dye taping for the short-term management of plantar fasciitis. J Am Podiatr Med Assoc 2005; 95:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/55\">",
"      Radford JA, Landorf KB, Buchbinder R, Cook C. Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial. BMC Musculoskelet Disord 2006; 7:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/56\">",
"      Crawford F, Atkins D, Young P, Edwards J. Steroid injection for heel pain: evidence of short-term effectiveness. A randomized controlled trial. Rheumatology (Oxford) 1999; 38:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/57\">",
"      Kalaci A, Cakici H, Hapa O, et al. Treatment of plantar fasciitis using four different local injection modalities: a randomized prospective clinical trial. J Am Podiatr Med Assoc 2009; 99:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/58\">",
"      Kamel M, Kotob H. High frequency ultrasonographic findings in plantar fasciitis and assessment of local steroid injection. J Rheumatol 2000; 27:2139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/59\">",
"      Kane D, Greaney T, Bresnihan B, et al. Ultrasound guided injection of recalcitrant plantar fasciitis. Ann Rheum Dis 1998; 57:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/60\">",
"      Tsai WC, Wang CL, Tang FT, et al. Treatment of proximal plantar fasciitis with ultrasound-guided steroid injection. Arch Phys Med Rehabil 2000; 81:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/61\">",
"      D'Ambrosia RD. Conservative management of metatarsal and heel pain in the adult foot. Orthopedics 1987; 10:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/62\">",
"      Sellman JR. Plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int 1994; 15:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/63\">",
"      Acevedo JI, Beskin JL. Complications of plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int 1998; 19:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/64\">",
"      Porter MD, Shadbolt B. Intralesional corticosteroid injection versus extracorporeal shock wave therapy for plantar fasciopathy. Clin J Sport Med 2005; 15:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/65\">",
"      Lee TG, Ahmad TS. Intralesional autologous blood injection compared to corticosteroid injection for treatment of chronic plantar fasciitis. A prospective, randomized, controlled trial. Foot Ankle Int 2007; 28:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/66\">",
"      Hawke F, Burns J, Radford JA, du Toit V. Custom-made foot orthoses for the treatment of foot pain. Cochrane Database Syst Rev 2008; :CD006801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/67\">",
"      Landorf KB, Keenan AM, Herbert RD. Effectiveness of foot orthoses to treat plantar fasciitis: a randomized trial. Arch Intern Med 2006; 166:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/68\">",
"      Bordelon RL. Practical guide to foot orthoses. J Musculoskel Med 1989; 6:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/69\">",
"      Tooms RE, Griffin JW, Green S, Cagle K. Effect of viscoelastic insoles on pain. Orthopedics 1987; 10:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/70\">",
"      Gudeman SD, Eisele SA, Heidt RS Jr, et al. Treatment of plantar fasciitis by iontophoresis of 0.4% dexamethasone. A randomized, double-blind, placebo-controlled study. Am J Sports Med 1997; 25:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/71\">",
"      Osborne HR, Allison GT. Treatment of plantar fasciitis by LowDye taping and iontophoresis: short term results of a double blinded, randomised, placebo controlled clinical trial of dexamethasone and acetic acid. Br J Sports Med 2006; 40:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/72\">",
"      Thomson CE, Crawford F, Murray GD. The effectiveness of extra corporeal shock wave therapy for plantar heel pain: a systematic review and meta-analysis. BMC Musculoskelet Disord 2005; 6:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/73\">",
"      Kudo P, Dainty K, Clarfield M, et al. Randomized, placebo-controlled, double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracoporeal shockwave therapy (ESWT) device: a North American confirmatory study. J Orthop Res 2006; 24:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/74\">",
"      Malay DS, Pressman MM, Assili A, et al. Extracorporeal shockwave therapy versus placebo for the treatment of chronic proximal plantar fasciitis: results of a randomized, placebo-controlled, double-blinded, multicenter intervention trial. J Foot Ankle Surg 2006; 45:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/75\">",
"      Marks W, Jackiewicz A, Witkowski Z, et al. Extracorporeal shock-wave therapy (ESWT) with a new-generation pneumatic device in the treatment of heel pain. A double blind randomised controlled trial. Acta Orthop Belg 2008; 74:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/76\">",
"      Buchbinder R, Ptasznik R, Gordon J, et al. Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis: a randomized controlled trial. JAMA 2002; 288:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/77\">",
"      Alvarez RG, Ogden JA, Jaakkola J, Cross GL. Symptom duration of plantar fasciitis and the effectiveness of Orthotripsy. Foot Ankle Int 2003; 24:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/78\">",
"      Babcock MS, Foster L, Pasquina P, Jabbari B. Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil 2005; 84:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/79\">",
"      D&iacute;az-Llopis IV, Rodr&iacute;guez-Ru&iacute;z CM, Mulet-Perry S, et al. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months. Clin Rehabil 2012; 26:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/80\">",
"      Young MA, Cook JL, Webster KE. The effect of topical wheatgrass cream on chronic plantar fasciitis: a randomized, double-blind, placebo-controlled trial. Complement Ther Med 2006; 14:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/81\">",
"      Micke O, Seegenschmiedt MH, German Cooperative Group on Radiotherapy for Benign Diseases. Radiotherapy in painful heel spurs (plantar fasciitis)--results of a national patterns of care study. Int J Radiat Oncol Biol Phys 2004; 58:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/82\">",
"      Allen BH, Fallat LM, Schwartz SM. Cryosurgery: an innovative technique for the treatment of plantar fasciitis. J Foot Ankle Surg 2007; 46:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/83\">",
"      Davis PF, Severud E, Baxter DE. Painful heel syndrome: results of nonoperative treatment. Foot Ankle Int 1994; 15:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/84\">",
"      Daly PJ, Kitaoka HB, Chao EY. Plantar fasciotomy for intractable plantar fasciitis: clinical results and biomechanical evaluation. Foot Ankle 1992; 13:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/85\">",
"      Sinnaeve F, Vandeputte G. Clinical outcome of surgical intervention for recalcitrant infero-medial heel pain. Acta Orthop Belg 2008; 74:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/86\">",
"      Barrett SJ, O'Malley R. Plantar fasciitis and other causes of heel pain. Am Fam Physician 1999; 59:2200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/87\">",
"      Kinley S, Frascone S, Calderone D, et al. Endoscopic plantar fasciotomy versus traditional heel spur surgery: a prospective study. J Foot Ankle Surg 1993; 32:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/88\">",
"      Saxena A. Uniportal endoscopic plantar fasciotomy: a prospective study on athletic patients. Foot Ankle Int 2004; 25:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/89\">",
"      Yeung EW, Yeung SS. A systematic review of interventions to prevent lower limb soft tissue running injuries. Br J Sports Med 2001; 35:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/90\">",
"      Milgrom C, Finestone A, Shlamkovitch N, et al. Prevention of overuse injuries of the foot by improved shoe shock attenuation. A randomized prospective study. Clin Orthop Relat Res 1992; :189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/91\">",
"      Martin RL, Irrgang JJ, Conti SF. Outcome study of subjects with insertional plantar fasciitis. Foot Ankle Int 1998; 19:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/92\">",
"      Wolgin M, Cook C, Graham C, Mauldin D. Conservative treatment of plantar heel pain: long-term follow-up. Foot Ankle Int 1994; 15:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/93\">",
"      Stephens MM. Haglund's deformity and retrocalcaneal bursitis. Orthop Clin North Am 1994; 25:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/94\">",
"      Kleiger B. The posterior calcaneal tubercle impingement syndrome. Orthop Rev 1988; 17:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/40/44681/abstract/95\">",
"      Brunner J, Anderson J, O'Malley M, et al. Physician and patient based outcomes following surgical resection of Haglund's deformity. Acta Orthop Belg 2005; 71:718.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7762 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-2FE80B8408-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44681=[""].join("\n");
var outline_f43_40_44681=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16389916\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PLANTAR FASCIITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H43544748\">",
"      - Approach to therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Initial therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H43544846\">",
"      - Resistant disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Surgical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      OTHER CAUSES OF HEEL PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8674983\">",
"      Achilles tendinopathy or tendonitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Haglund's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Calcaneal spurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16389916\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16389923\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7762\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7762|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?27/51/28478\" title=\"diagnostic image 1\">",
"      Heel spur",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7762|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/7/19573\" title=\"figure 1\">",
"      Plantar anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7762|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/12/21696\" title=\"picture 1\">",
"      Palpating the plantar fascia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/40/27279\" title=\"picture 2\">",
"      Padded foot splint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/28/11712\" title=\"picture 3\">",
"      Calf stretch PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/9/20627\" title=\"picture 4\">",
"      Foot ankle circles PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/29/468\" title=\"picture 5\">",
"      Toe curls PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/60/21442\" title=\"picture 6\">",
"      Toe towel curls PI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/12/17603\" title=\"picture 7\">",
"      Low Dye foot taping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/16/17679\" title=\"picture 8\">",
"      Injection for plantar fasciitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/49/32537?source=related_link\">",
"      Achilles tendinopathy and tendon rupture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34296?source=related_link\">",
"      Ankle sprain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/50/7978?source=related_link\">",
"      Clinical manifestations and diagnosis of Paget disease of bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/52/13130?source=related_link\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/41/21146?source=related_link\">",
"      Overview of cancer pain syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42233?source=related_link\">",
"      Overview of lower extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/34/4649?source=related_link\">",
"      Overview of osteomyelitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/19/23866?source=related_link\">",
"      Overview of stress fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/42/38561?source=related_link\">",
"      Patient information: Heel pain (caused by plantar fasciitis) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/5/40018?source=related_link\">",
"      Patient information: Heel pain (caused by plantar fasciitis) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1030?source=related_link\">",
"      Posterior and medial ankle tendinopathies not involving the Achilles tendon",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_40_44682="ECG sinus rhythm WPW";
var content_f43_40_44682=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76226%7ECARD%2F67181&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76226%7ECARD%2F67181&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1147px;\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a patient in sinus rhythm with Wolff-Parkinson-White (WPW) pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nearly full preexcitation is manifest in normal sinus rhythm on the 12 lead ECG in this patient with a short accessory pathway refractory period. The ventricular complex in preexcitation is a fusion of the impulse that preexcites the ventricles due to rapid conduction through an accessory pathway and of the impulse that takes the usual route through the AV node; this fusion creates the delta wave that is characteristic of Wolff-Parkinson-White ECG pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 466px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal sinus rhythm at a rate of 71 beats/min, a P wave axis of 45&deg;, and a PR interval of 0.15 sec.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1272px;\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    ECG in Wolff-Parkinson-White",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The 12 lead ECG shows the typical features of Wolff-Parkinson-White; the PR interval is short (*) and the QRS duration prolonged as a result of a delta wave (arrow), indicating ventricular preexcitation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Martin Burke, DO.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44682=[""].join("\n");
var outline_f43_40_44682=null;
var title_f43_40_44683="Heparin protocol I";
var content_f43_40_44683=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Example of a non-weight-based intravenous heparin protocol: Part I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Initial intravenous heparin bolus: 5000 units.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Continuous intravenous heparin infusion: commence at 42 mL/hour of 20,000 units (1680 units/hour) in 500 mL of two-thirds dextrose and one-third saline (a 24-hour heparin dose of 40,320 units), except in the following patients, in whom heparin infusion will be commenced at a rate of 31 mL/hour (1240 units/hour) (ie, a 24-hour dose of 29,760 units).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients who have undergone surgery within the previous two weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with a previous history of peptic ulcer disease, gastrointestinal or genitourinary bleeding.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with (thrombotic) stroke within the previous two weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with a platelet count &lt;150,000/microL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Patients with miscellaneous reasons for a high risk of bleeding (eg, hepatic failure, renal failure, or vitamin K deficiency).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Heparin dose adjusted using the aPTT. The aPTT is performed in all patients as outlined below:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        4 to 6 hours after commencing heparin; the heparin dose is then adjusted according to the nomogram shown in Heparin Protocol-II until the aPTT is within the therapeutic range.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Thereafter, the aPTT will be performed once daily. If the value is outside the therapeutic range, the heparin dose is then adjusted according to the nomogram shown in Heparin Protocol-II until the aPTT is within the therapeutic range.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992; 152:1589.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44683=[""].join("\n");
var outline_f43_40_44683=null;
var title_f43_40_44684="Empiric intravenous antibiotic therapy for human bite wounds";
var content_f43_40_44684=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80019&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80019&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Empiric intravenous antibiotic therapy for human bite wounds",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Antibiotic",
"      </td>",
"      <td class=\"subtitle1\">",
"       Dosing for adults",
"      </td>",
"      <td class=\"subtitle1\">",
"       Dosing for children",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Agents of choice for empiric coverage include:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\" colspan=\"3\">",
"       Monotherapy with a beta-lactam/beta-lactamase inhibitor, such as one of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Ampicillin-sulbactam",
"      </td>",
"      <td class=\"sublist_other\">",
"       3 g every six hours",
"      </td>",
"      <td class=\"sublist_other\">",
"       50 mg/kg per dose (based on ampicillin component) every six hours*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Piperacillin-tazobactam",
"      </td>",
"      <td class=\"sublist_other\">",
"       4.5 g every eight hours",
"      </td>",
"      <td class=\"sublist_other\">",
"       125 mg/kg per dose (based on piperacillin component) every eight hours*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Ticarcillin-clavulanate",
"      </td>",
"      <td class=\"sublist_other\">",
"       3.1 g every four hours",
"      </td>",
"      <td class=\"sublist_other\">",
"       50 mg/kg per dose (based on ticarcillin component) every four hours*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       <p>",
"        A third generation cephalosporin such as ceftriaxone",
"       </p>",
"       <p>",
"        <strong>",
"         PLUS",
"        </strong>",
"       </p>",
"       <p>",
"        Metronidazole",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        1 g every 24 hours",
"       </p>",
"       <p>",
"        <strong>",
"         PLUS",
"        </strong>",
"       </p>",
"       <p>",
"        500 mg every eight hours",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        100 mg/kg per dose every 24 hours (maximum 1 g per dose)",
"       </p>",
"       <p>",
"        <strong>",
"         PLUS",
"        </strong>",
"       </p>",
"       <p>",
"        10 mg/kg per dose every eight hours (maximum 500 mg per dose)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"3\">",
"       Alternative empiric regimens include:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       <p>",
"        A fluoroquinolone such as levofloxacin",
"       </p>",
"       <p>",
"        <strong>",
"         PLUS",
"        </strong>",
"       </p>",
"       <p>",
"        Metronidazole",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        500 mg daily",
"       </p>",
"       <p>",
"        <strong>",
"         PLUS",
"        </strong>",
"       </p>",
"       <p>",
"        500 mg every eight hours",
"       </p>",
"      </td>",
"      <td>",
"       Use fluoroquinolones with caution in children &lt;18 years of age",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2_start\" colspan=\"3\">",
"       Monotherapy with a carbapenem&bull;, such as one of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Imipenem-cilastatin",
"      </td>",
"      <td class=\"sublist_other\">",
"       500 mg every six hours",
"      </td>",
"      <td class=\"sublist_other\">",
"       25 mg/kg per dose every six hours (maximum 500 mg per dose)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Meropenem",
"      </td>",
"      <td class=\"sublist_other\">",
"       1 g every 8 hours",
"      </td>",
"      <td class=\"sublist_other\">",
"       20 mg/kg per dose every 8 hours (maximum 1 g per dose)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Ertapenem",
"      </td>",
"      <td class=\"sublist_other\">",
"       1 g daily",
"      </td>",
"      <td class=\"sublist_other\">",
"       15 mg/kg per dose every twelve hours for children up to 12 years of age (maximum 500 mg per dose)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Maximum pediatric dose: see adult dose",
"     <br>",
"      &bull; Carbapenems should not be used for patients with history of immediate-type hypersensitivity to beta-lactams.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44684=[""].join("\n");
var outline_f43_40_44684=null;
var title_f43_40_44685="CRS IPHC MPM results";
var content_f43_40_44685=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Results of selected series of cytoreduction and HIPEC for patients with MPM",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Center",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Optimal cytoreduction* (percent)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        HIPEC agents",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Survival",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Prognostic factors",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Preoperative mortality/morbidity (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Median follow-up, months",
"       </td>",
"       <td class=\"subtitle2\">",
"        Median survival, months",
"       </td>",
"       <td class=\"subtitle2\">",
"        Overall (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Loggie B; 2001 (phase II trial). Wake Forest, NC.",
"       </td>",
"       <td rowspan=\"4\">",
"        12",
"       </td>",
"       <td rowspan=\"4\">",
"        5 (42)",
"       </td>",
"       <td rowspan=\"4\">",
"        MMC",
"       </td>",
"       <td rowspan=\"4\">",
"        45",
"       </td>",
"       <td rowspan=\"4\">",
"        34",
"       </td>",
"       <td>",
"        1 year: 60",
"       </td>",
"       <td rowspan=\"4\">",
"        NR",
"       </td>",
"       <td rowspan=\"4\">",
"        8/NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 years: 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5 years: 33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7 years: 33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Deraco M; 2003 (phase II multi-institutional). Milan.",
"       </td>",
"       <td>",
"        61",
"       </td>",
"       <td>",
"        46 (74)",
"       </td>",
"       <td>",
"        Cisplatin + MMC or cisplatin + doxorubicin",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        5 years: 54",
"       </td>",
"       <td>",
"        Optimal resection",
"       </td>",
"       <td>",
"        0/23 (grade 3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Feldman A; 2003 (phase II trial). NCI, Bethesda.",
"       </td>",
"       <td rowspan=\"2\">",
"        49",
"       </td>",
"       <td rowspan=\"2\">",
"        43 (88)",
"       </td>",
"       <td rowspan=\"2\">",
"        Cisplatin (n = 49); with 5-FU/paclitaxel (n = 35)",
"       </td>",
"       <td rowspan=\"2\">",
"        28",
"       </td>",
"       <td rowspan=\"2\">",
"        92&bull;",
"       </td>",
"       <td>",
"        1 year: 86",
"       </td>",
"       <td rowspan=\"2\">",
"        Optimal resection, age &lt;60, no deep invasion",
"       </td>",
"       <td rowspan=\"2\">",
"        0/36",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 years: 59",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Brigand C; 2006 (retrospective). Centre Hospitale Lyon Sud.",
"       </td>",
"       <td rowspan=\"3\">",
"        15",
"       </td>",
"       <td rowspan=\"3\">",
"        11 (73)",
"       </td>",
"       <td rowspan=\"3\">",
"        Cisplatin + MMC",
"       </td>",
"       <td rowspan=\"3\">",
"        47",
"       </td>",
"       <td rowspan=\"3\">",
"        36",
"       </td>",
"       <td>",
"        1 year: 69",
"       </td>",
"       <td rowspan=\"3\">",
"        Optimal resection, extent of carcinomatosis",
"       </td>",
"       <td rowspan=\"3\">",
"        0/40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 years: 43",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5 years: 29",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Deraco M; 2006 (phase II trial). Milan.",
"       </td>",
"       <td rowspan=\"3\">",
"        49",
"       </td>",
"       <td rowspan=\"3\">",
"        43 (88)",
"       </td>",
"       <td rowspan=\"3\">",
"        Cisplatin + MMC or cisplatin + doxorubicin",
"       </td>",
"       <td rowspan=\"3\">",
"        20",
"       </td>",
"       <td rowspan=\"3\">",
"        NR",
"       </td>",
"       <td>",
"        1 year: 88",
"       </td>",
"       <td rowspan=\"3\">",
"        Optimal resection, mitotic count",
"       </td>",
"       <td rowspan=\"3\">",
"        0/27",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 years: 65",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5 years: 57",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Yan T; 2007 (retrospective). Washington Hospital Center.",
"       </td>",
"       <td rowspan=\"3\">",
"        70",
"       </td>",
"       <td rowspan=\"3\">",
"        52 (74)",
"       </td>",
"       <td rowspan=\"3\">",
"        Cisplatin + doxorubicin",
"       </td>",
"       <td rowspan=\"3\">",
"        35",
"       </td>",
"       <td rowspan=\"3\">",
"        59",
"       </td>",
"       <td>",
"        1 year: 82",
"       </td>",
"       <td rowspan=\"3\">",
"        Optimal resection, female gender",
"       </td>",
"       <td rowspan=\"3\">",
"        3/41 (grade 3 to 4)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 years: 57",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5 years: 49",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hesdorffer M; 2008 (phase II trial). Columbia-Presbyterian, NY.",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        Cisplatin + MMC&Delta;",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        3 years: 67",
"       </td>",
"       <td>",
"        Bulky disease, histology, pleural plaques",
"       </td>",
"       <td>",
"        0/19",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Chua T; 2009 (retrospective). Sydney, Australia.",
"       </td>",
"       <td rowspan=\"2\">",
"        20",
"       </td>",
"       <td rowspan=\"2\">",
"        19 (95)",
"       </td>",
"       <td rowspan=\"2\">",
"        Cisplatin + doxorubicin",
"       </td>",
"       <td rowspan=\"2\">",
"        48",
"       </td>",
"       <td rowspan=\"2\">",
"        30",
"       </td>",
"       <td>",
"        1 year: 78",
"       </td>",
"       <td rowspan=\"2\">",
"        Histology, subtype, optimal resection",
"       </td>",
"       <td rowspan=\"2\">",
"        5/20 (grade 3 to 4)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 years: 46",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Yan T; 2009 (multi-institutional series)",
"       </td>",
"       <td rowspan=\"3\">",
"        405",
"       </td>",
"       <td rowspan=\"3\">",
"        187 (46)",
"       </td>",
"       <td rowspan=\"3\">",
"        Cisplatin + doxorubicin (n = 336); cisplatin, MMC, or both (n = 65)",
"       </td>",
"       <td rowspan=\"3\">",
"        33",
"       </td>",
"       <td rowspan=\"3\">",
"        53",
"       </td>",
"       <td>",
"        1 year: 81",
"       </td>",
"       <td rowspan=\"3\">",
"        Histology, optimal resection, absence of lymph node metastases",
"       </td>",
"       <td rowspan=\"3\">",
"        2/31 (grade 3 to 4)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 years: 60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5 years: 47",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HIPEC: hyperthermic intraperitoneal chemotherapy; NR: not reported; MMC: Mitomycin C.",
"     <br>",
"      * Optimal cytoreduction is defined as no residual tumor deposits &gt;2.5 mm.",
"      <br>",
"       &bull; This series included patients (36 percent of all in the report) with low grade mesothelioma variants.",
"       <br>",
"        &Delta; These investigators employ an aggressive multimodality approach with cytoreductive surgery followed by four months of intraperitoneal cisplatin, doxorubicin and interferon via indwelling catheter, followed by secondary cytoreductive surgery with IHPC (cisplatin plus MMC) and then whole abdominal radiotherapy.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44685=[""].join("\n");
var outline_f43_40_44685=null;
var title_f43_40_44686="Unicornuate uterus";
var content_f43_40_44686=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F58931&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F58931&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Unicornuate uterus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44686=[""].join("\n");
var outline_f43_40_44686=null;
var title_f43_40_44687="Pulmonary LAM HMB 45";
var content_f43_40_44687=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Microscopic features of lymphangioleiomyomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 223px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High magnification photomicrograph showing immunohistochemical staining for the melanogenesis-associated marker HMB-45. This unique phenotype is an important diagnostic characteristic in difficult cases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey L Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_40_44687=[""].join("\n");
var outline_f43_40_44687=null;
      